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Summary 
The type I interferon-induced Mx-proteins play a pivotal role in the first line of defence 
against viruses. Human MxA has been shown to be active against a large number of 
viruses including Influenza A virus, vesicular stomatitis virus, Bunyaviruses and 
Thogotovirus, but the exact molecular mechanism remains to be elucidated. There is 
evidence that Mx-proteins exert their antiviral activity via direct protein interactions. 
However, no direct interaction between Mx-proteins and any viral protein of Influenza A 
virus is known. Therefore we assessed whether cellular proteins, which are required for 
Influenza A virus replication represent a possible target of MxA. UAP56 and URH49 are 
two DExD/H box RNA helicases involved in mRNA export and spliceosome assembly, 
UAP56 was previously shown to stimulate influenza RNA synthesis in vitro. We were 
able to show a direct interaction between UAP56/URH49 and human MxA. Using a split 
GFP approach we demonstrated an interaction of UAP56/URH49 and MxA in the 
cytoplasm. Our results confirm the hypothesis of UAP56/URH49 shuttling between 
nucleus and cytoplasm. In addition UAP56 and URH49 are required for an efficient 
influenza A virus replication. Knockdown of UAP56 resulted in a 200-fold titer reduction 
for avian influenza A virus. Furthermore, we demonstrated that UAP56 is required during 
influenza A virus infection to prevent the formation of double stranded RNA, thereby 
preventing an activation of the type I interferon system. In summary we describe a novel 
interaction partner of MxA that is important for influenza A virus replication. In this study 
we propose a new mechanism how MxA exerts its antiviral activity by targeting cellular 
RNA helicases. 
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Zusammenfassung 
Mx-Proteine sind Teil des Typ I Interferon-Systems und spielen eine wichtige 
Rolle bei der Bekämpfung zahlreicher Viren. Das menschliche MxA Protein hat 
antivirale Wirkung gegen eine Vielzahl von Viren, unter anderem gegen Influenza 
A Viren, Vesicular Stomatitis Viren, Bunyaviren und Thogotoviren. Der 
molekulare Mechanismus ist jedoch für die meisten Viren bisher nicht bekannt. 
Für Influenza A Viren konnte keine direkte Interaktion zwischen Mx-Proteinen 
und viralen Proteinen beschrieben werden. Unsere Fragestellung lautete, ob 
zelluläre Proteine, die für die Replikation von Influenza A Viren wichtig sind, ein 
mögliches Ziel von MxA sind. UAP56 und URH49 sind zwei DExD/H-box RNA 
Helikasen die für den Zusammenbau des Spliceosomes und mRNA Export 
verantwortlich sind. UAP56 stimuliert zudem die Influenza A Virus RNA Synthese 
in vitro. Wir konnten eine direkte Interaktion zwischen UAP56/URH49 und 
humanem MxA zeigen. Mittels eines Split-GFP Systems konnten wir zeigen, 
dass diese Interaktion im Zytoplasma stattfindet. Unsere Ergebnisse  bestätigen 
die Hypothese, dass UAP56 und URH49 zwischen dem Nukleus und dem 
Zytoplasma “shuttlen” können. Zudem sind UAP56 und URH49 wichtig für eine 
effiziente Replikation von Influenza A Viren. Durch die Herunterregulierung von 
UAP56 konnten wir eine 200-fache Reduktion des Titers für aviäre Influenza A 
Viren zeigen. Außerdem konnten wir zeigen, dass UAP56 die Bildung von 
Doppelstrang-RNA während der Infektion von Influenz A Viren verhindert, welche 
das Typ I Interferon-System aktivieren würde. Zusammenfassend beschreiben 
wir hier einen neuen Interaktionspartner von MxA, welcher für die Replikation von 
Influenza A Viren wichtig ist. Wir schlagen in dieser Arbeit einen neuen 
Mechanismus für MxA vor, in welchem zelluläre RNA Helikasen und deren 
Interaktion mit MxA ein Teil des antiviralen Mechanismus sind. 
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Introduction 
The influenza A virus 
 
Influenza virus classification 
Influenza A viruses (IAV) belong to the family of Orthomyxoviridae and can be 
divided into three different genera depending on the antigenic differences of their 
nucleo- and matrix proteins: type A, B and C. They also differ with respect to host 
range, variability of the surface glycoproteins, genome organization and 
morphology. Influenza A viruses are responsible for major pandemic and 
epidemic outbreaks throughout the past decades, as well as for the annual 
epidemic influenza outbreaks. 
Influenza A viruses have the broadest host range of all three genera and are able 
to infect a large variety of mammals and birds. The main reservoir for Influenza A 
viruses are wild aquatic birds (Figure 1). 
Influenza A viruses are further classified into subtypes based on the antigenicity 
of their haemagglutinin (HA) and neuraminidase (NA) surface proteins. So far 16 
HA subtypes and 9 NA subtypes have been described [2]. The full nomenclature 
for each new isolate includes the type of virus, host of origin (except for human 
isolates), geographical site of isolation, strain number, and year of isolation. The 
antigenic serotype is given in parentheses, for example A/Puerto 
Rico/34/1908(H1N1). So far no subtypes have been described for Influenza B 
and C viruses. 
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Influenza A viruses are unique in their ability to cause recurrent seasonal 
epidemics of varying severity, as well as global pandemics which have been a 
major burden for humans in the last centuries. In the past centuries four major 
pandemics have been reported, the “Spanish Flu” (1918, H1N1), “Asian Flu” 
(1957, H2N2), “HongKong-Flu” (1968, H3N2) and the “Russian-Flu” (1977, 
H1N1). For the “Spanish-Flu” over 40 million deaths are estimated which 
accounts for more deaths than World War I [3]. The “Russian-Flu” is considered 
important nowadays, because it reintroduced the H1N1 as a circulating strain in 
the human population, today H1N1 and H3N2 strains are circulating in the human 
population. 
Just recently in 2009 a new pandemic has spread over the globe, the so called 
“Swine-Flu” representing a novel H1N1 strain, which is a reassortant from avian, 
pig and human IAVs and caused a global pandemic in 2009/2010 [4]. 
 
Figure 1. The reservoir of influenza A virus. The hypothesis is that wild aquatic birds are the 
primordial reservoir for all avian and mammalian influenza A viruses. Direct transmissions which 
have been demonstrated are shown with solid lines, whereas possible direct transmissions are 
shown with dotted lines.The five different host groups are based on phylogenetic analysis of the 
nucleoprotein genes of a large number of different influenza viruses [1]. 
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Influenza A virus morphology and genome structure 
Influenza A viruses are enveloped viruses whose genome consists of eight single 
stranded RNA segments of negative polarity, which code for at least 10 viral 
proteins [5]. The genome is about 13 kilo base pairs (kb) in size and the eight 
segments have a length ranging between 890 to 2341 bases. IAV particles are 
pleomorphic and have a size of 80-120 nm in diameter [5].  
Each segment contains short 5` and 3` untranslated regions which have 
promoter activity and are partially complementary to form a so called “cork-
screw” structure, in addition they are required for the recognition of the vRNA by 
the viral polymerase [6]. 
 
Figure 2: Schematic view of the influenza A virion and the ribonucleoproteincomplex 
(RNP). A schematic view of the virion is shown including all nine proteins in the virion, the NS1 
protein cannot be found in the virion but only in infected cells. The negative stranded RNA is 
shown in a complex with the nucleoprotein and the polymerase subunits, also called the RNP. 
(Adapted from Jovan Pavlovic) 
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The lipid envelope of the virion is derived from the host cell membrane during 
viral budding from the cell surface and consists of a lipid bilayer. The viral 
glycoproteins HA and NA are encoded by the viral gene segments 4 and 6 and 
are embedded in the membrane of the virion. The HA forms a trimer which 
consists of three individual HA monomers. HA is synthesized as a single 
polypeptide chain (HA0) and gets proteolytically cleaved into the active form, 
which consists of the two distinct subunits HA1 and HA2 connected by a disulfide 
bond [5, 7, 8]. Cleavage of HA0 is essential for HA to mediate membrane fusion 
between the viral and the cellular membrane and represents a key step in the 
viral lifecycle [9]. In addition HA1 is the major antigenic epitope of IAV against 
which host derived neutralizing antibodies are directed. The HA2 forms the stem 
structure of the viral spike and contains a region of 20 amino acids at the N-
terminus which is generally referred to as “fusion peptide” since it triggers the 
fusion between the viral and host cell membrane upon virus entry [9].  
The NA is the second major surface antigen of IAV and is important for efficient 
viral budding. It displays enzymatic activity against terminal sialic acid residues 
linked to a sugar residue [5, 10]. NA is also of importance because it cleaves the 
sialic acids, which serve as the IAV cellular receptor, from the cell surface and 
therefore prevents a super-infection, as well as aggregation of newly formed 
virions on the cell surface. 
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Figure 3: The Influenza A virus proteins and their functions. Adapted from [11] 
 
The Matrix protein 2 (M2) is the third integral membrane protein, and consists of 
a homotetramer. M2 is a pH-activated proton channel and is essential for 
uncoating in the viral life cycle. It mediates proton uptake from the acidified 
endosome into the viral particle and thereby disrupts the interaction between the 
viral genome and the matrix protein 1 (M1) [5, 12, 13].  
The viral RNA is assembled with the RNA-dependent RNA polymerase (RDRP), 
which is a complex of PB1, PB2 and PA which form the viral 
ribonucleoproteincomplex together with the nucleoprotein (vRNP) [5] (Figure 2). 
As the main component of the RNP the influenza NP encapsidates the viral 
genome but in addition, also plays a major role in transcription of the RNA, 
replication and packaging [14]. The IAV NP is associated with the viral RNA, 
serving as a scaffold and also requires M1 to form helical structures [15]. It has 
been shown that free NP is needed for vRNA synthesis, which was believed to 
happen late in viral infection. Recently it was shown that vRNA synthesis occurs 
throughout the whole time of infection but only seems to be stable if enough 
RDRP complexes and NP are present to protect the newly synthesized vRNA 
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[16-18]. Upon export of the viral RNPs via the CRM-1 export pathway, NP 
remains tightly associated with the vRNA, PB1 and PB2 [14]. A layer of M1 
protein surrounds the viral RNP. M1 is the most abundant protein of IAV and is 
thought to serve as an adaptor between the lipid envelope and the viral RNPs. In 
addition M1 is a maturation marker in the IAV replication, since association of M1 
to the RNPs is important for RNP export later in the infection cycle [10, 13, 19-
21]. 
Like segment 7, segment 8 also encodes for two proteins, the non-structural 
protein 1 (NS1) and 2 (NS2/NEP), NS2 mRNA is spliced from the primary mRNA, 
whereas the unspliced mRNA codes for NS1 (Figure 3).  
The NS1 protein is not found in the virion and is only present in infected cells. 
NS1 was shown to be a viral antagonist of the IFN system (IFNα/β), since a NS1 
deficient strain can only replicate in cells, which lack crucial parts of the IFN 
system [22, 23]. Furthermore, NS1 has been shown to have ssRNA and dsRNA 
binding activity, therefore it is able to sequester viral dsRNA and downregulate 
the activation of the dsRNA activated protein kinase R (PKR), NF-κB and IFN 
regulatory factor 3 (IRF-3) [24-26]. Recently, IAV NS1 was described to inhibit 
the cellular RNA helicase retinoic acid-inducible gene I (RIG-I), which is a 
cytoplasmic sensor for ssRNA bearing 5`-phosphates [27, 28]. RIG-I forms stable 
complexes with RNA containing a 5`-phosphate and during infection NS1 is 
recruited to such complexes via an RNA binding domain, thereby preventing a 
sensing of the viral RNA [27]. Additional studies have also shown an 
anti-apoptotic effect of NS1 [29].  
In contrast to NS1, the NS2 protein is present in low copies in the virion. NS2 is 
nowadays also called nuclear export protein (NEP) since it is important for the 
export of newly synthesized RNPs from the nucleus into the cytoplasm [30]. 
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Replication of influenza A virus 
Upon infection IAV binds to sialic acid residues on the cell surface which are 
ubiquitously present on most cells. IAV mainly infects cells in the upper and lower 
respiratory tract, but can also infect macrophages or dendritic cells [10, 31]. 
Different IAV HAs show receptor specificity for varying glycosidic linkages 
between the terminal sialic acid and the following galactose residue [9]. Human 
IAVs primarily bind to an α2-6 attached sialic acid, whereas avian IAVs bind to an 
α2-3 attached sialic acid [32].  
The binding of the virion to the cell surface induces a receptor-mediated 
endocytotic uptake of the virion, during which the virus particles are internalized 
by the host cell plasma membrane. Subsequent fusion of the vesicles with 
endosomal particles leads from mild acidic early endosomal compartments to late 
more acidic compartments. A crucial step in the IAV life cycle is the fusion of the 
viral and the endosomal membrane at a pH of about 5-6. Upon pH decrease the 
HA undergoes major conformational changes, and the fusion peptide of HA2 is 
exposed which leads to an insertion into the endosomal membrane followed by 
fusion of the two membranes [8, 9] (Figure 4).  
The M2 protein serves as an ion channel and is important for the pH dependent 
uncoating (loosens the interaction between NP and M1) and release of the viral 
RNPs into the cytoplasm of the cell and further transport via the nuclear pore 
complex (NPC) to the nucleus. This transport is mediated via a nuclear 
localisation signal (NLS) in the NP [14, 33] (Figure 4).  
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Figure 4: Influenza A virus replication cycle. Schematic view of the steps in the IAV replication 
cycle. 
 
Once the RNPs are transported into the host-cell nucleus the associated 
polymerase complex begins with the primary transcription of mRNA, which also 
requires the cellular RNA polymerase II [34]. The viral RDRP cannot initiate IAV 
mRNA synthesis since m7GpppXm-containing capped primers (10–13nt long, 
containing 5`-GCA-3` at their 3` proximal ends) are needed. This process 
involves “stealing” of the 5`cap sequence from cellular mRNAs and is commonly 
referred to as “cap-snatching”. Hereby, the endonuclease activity resides in the 
PA subunit of the polymerase, whereas PB1 is required for elongation of the 
nascent mRNA [35]. In addition to the production of viral mRNAs cap-snatching 
also induces a “host-cell shutoff” in favoring synthesis of viral proteins over 
cellular ones [10]. Transcription of viral mRNA continues until it reaches the 
polyadenylation site located 15-22nt from the 5`end of the vRNA. 
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The vRNA (minus strand) does not only serve as a template for mRNA it is also a 
template for the RDRP to produce viral cRNA (plus strand), which in turn leads to 
an increased synthesis of vRNA. 
In contrast to mRNA synthesis vRNA and cRNA can be transcribed in a primer-
independent manner leading to 5` triphosphorylated ends. Additionally, the poly-
A signal is ignored in cRNA synthesis [5, 14]. Export of viral mRNAs occurs via 
different export pathways, involving NFX1 and several additional factors [36]. 
After their translation PB1, PB2, PA and NP are transported back to the nucleus, 
whereas HA, NA and M2 are translated into the lumen of the endoplasmic 
reticulum (ER) and undergo an oligomerization before being transported to the 
golgi and subsequently to the plasma membrane [5, 10, 37]. While being 
transported through the ER and the golgi, HA and NA are heavily glycosylated 
and further processed.  
In contrast to the viral glycoproteins newly synthesized PB1, PB2, PA and NP are 
transported to the nucleus where they associate with newly synthesized vRNA to 
form viral RNPs. Nuclear export of the vRNPs is mediated by NS2 and is CRM-1 
dependent [30]. After being transported to the cytoplasm, vRNPs associate with 
viral membrane proteins and budding of the virions occurs at the plasma 
membrane of the infected cell [20, 30, 38].  
 
Antigenic variation of influenza A virus 
Influenza viruses are an ongoing risk for the human population, because of their 
ability to exchange genome segments and a high error rate of the RDRP. In 
combination those two mechanisms increase the diversity of the IAV antigenicity. 
Point mutations in the IAV genome are commonly referred to as “Antigenic 
drift”and mainly occur in the HA and NA glycoproteins. This allows the virus to 
adapt to selective pressure given by circulating neutralizing antibodies [39, 40]. 
Virus strains resulting from “antigenic drift” usually result in small epidemics, 
since partial immunity from circulating cross-neutralizing antibodies exists. 
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Highly virulent strains, which cause major pandemics, occur via a mechanism 
called “antigenic shift”. “Antigenic shift” is the change genomic segments to form 
a new subtype of influenza A virus. One ore more viral segments can be 
exchanged between different virus strains and the new virus is therefore 
immunologically distinct from previously the circulating isolates [10]. Most 
commonly pandemic strains are a mixture of both avian and human IAVs, but the 
recent pandemic in 2009 (H1N1) was a variant containing human and avian 
segments as well as segments with swine origin, which proofs the theory of 
swine being a “mixing vessel” for IAV [41]. 
Currently only H1N1 and H3N2 strains are circulating in the human population. 
The 2009 pandemic H1N1 strain appears to have replaced the former circulating 
H1N1 strain. 
DEAD-box RNA helicases 
 
The DEAD box family of proteins includes a large number of proteins which play 
important roles in the RNA metabolism. Different members of this family have 
been shown to act as RNA helicases which are involved in unwinding RNA 
structures, dissociation of RNA-protein complexes in cellular processes, 
transcription, splicing, RNA export and translation [42]. 
DEAD box helicases belong to a large superfamily (SF2) of proteins which is 
conserved throughout bacteria, viruses and humans. All proteins contain seven 
or eight conserved motifs whose characteristics are used to subgroup members 
into individual families [43]. The name of the family is dervived from the amino-
acid sequence D-E-A-D (Asp-Glu-Ala-Asp) from a specific motif. Besides 
DEAD-box helicases very closely related families like DEAH, DExH and 
DExD-box helicases exist, which are commonly referred to as DExD/H-box 
helicases [43, 44] (Figure 5).  
Since the early 1980s over 500 DEAD-box proteins and RNA helicases from the 
DEAD-box related families have been described [45]. 
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Figure 5: Conserved motfis in the DEAD-box and related DExD/H-box families. Sequences 
of the conserved motfis from the S. Cerevisiae elF4A (DEAD-box protein), Prp2 (DEAH-box 
protein), NS3 (DECH helicase from hepatitis C virus) and Ski2 (DExH, Ski2 family). From [46] 
 
Despite the ubiquitous function of DEAD-box proteins in processes involving 
RNA many precise roles or functions still remain unclear and have to be further 
elucidated. As a subgroup of DEAD-box helicases, DExD/H-box helicases can 
fulfill almost all functions involving RNA activities. Since the helicases UAP56 and 
URH49 belong to the DExD/H-box helicases a short introduction on this particular 
subgroup will be given. 
 
UAP56 and URH49 
UAP56 has been first described in 1997 as U2AF65-associated protein of 56 kDa 
required for U2 snRNP addition to the branch point region during pre-
spliceosome formation in vitro [47]. In addition to UAP56 a close paralogue, 
which is 90% identical to UAP56 has been described and termed URH49 
(UAP56-related helicase, 49 kDa, also called DDX39) [48] (Figure 6). 
Both DExD/H-box helicases are involved in mRNA splicing and nuclear export of 
mRNAs [49] and have been described to be essential in eukaryotes. In lower 
eukaryotes like S. Cerevisiae or D.melanogaster only one protein corresponding 
to UAP56 is expressed, whereas in mice and humans UAP56 and URH49 are 
expressed. Interestingly, birds only express UAP56 and lack the close paralogue, 
a fact that will be further addressed in the discussion section of this work. 
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Although both proteins are 90% identical and exhibit similar functions they are 
encoded on different chromosomes in the human genome (UAP56 on 
chromosome 6 and URH49 on chromosome 19). Functional studies of UAP56 
and URH49 show the ability of both to complement the otherwise lethal deletion 
of Sub2, the yeast homologue [48]. In addition both proteins have been shown to 
interact with the cellular mRNA export factor ALY/REF, recruiting it to spliced 
mRNA-protein complexes, which is needed for export of mRNA [50]. Since most 
of the studies regarding the function of DExD/H-box helicases have been 
performed with UAP56 but not URH49, we will mainly focus on the function of 
UAP56 in this work. 
UAP56 is one of the few DExD/H-box proteins whose crystal structure has been 
solved for the whole protein, which gives a closer insight into possible 
mechanisms and requirements of the helicase in cellular processes [51, 52]. 
Further biochemical characterization of UAP56 revealed an involvement in 
spliceosome assembly and mRNA export. UAP56 was shown to be an RNA-
stimulated ATPase as well as an RNA helicase which can unwind dsRNA 
substrates with 5` or 3` overhangs and blunt ends in vitro [53].  
During transcription of a gene, splicing of the nascent mRNA (pre-mRNA) is a 
critical event and is carried out by the spliceosome complex. Intron containing 
pre-mRNAs have to be spliced to remove the introns before the mRNA can be 
transported out of the nucleus for translation [54]. During this process UAP56 
recruits the ALY/REF adaptor protein to the mRNA prior to nuclear export [50, 
55]. The heterodimeric export factor TAP/NFX1 binds to ALY/REF, displacing 
UAP56 from the complex, leading to export of the mature mRNA through the 
nuclear pore complex [56]. 
UAP56 could also be shown to be important for the export of mRNAs derived 
from either intronless or intron containing transcripts, which makes UAP56 not 
exclusively coupled to export of spliced mRNAs [50, 57]. 
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Figure 6: Sequence identity of UAP56 and URH49 (termed DDX39). Sequence identity 
between the human DExD/H proteins UAP56 and URH49 is shown in blue.  
 
Besides important cellular functions UAP56 was also described to interact with N-
terminus of IAV NP and enhance viral RNA synthesis [58]. So far nothing is 
known about URH49 and a possible interaction with IAV NPs or an enhancing 
effect on viral RNA synthesis. 
Recently Read and Digard showed that the viral M1, M2 and NS1 mRNAs are 
exported via an UAP56/NXF1 dependent pathway, whereas segments 1 and 5 
(PB2 and NP) seemed to be less dependent on UAP56 [36]. Export of unspliced 
and spliced mRNAs is dependent on UAP56, whereas intronless mRNAs might 
use additional export pathways [36]. Concerning export of IAV mRNAs nothing is 
known about URH49. These findings about export of viral mRNAs can be 
combined with different suggestions that IAV needs to recruit several cellular 
factors for an efficient viral replication. UAP56 and URH49 have also been 
described to be involved in the export of mRNAs and replication of human 
cytomegalovirus (HCMV) [59]. Both helicases were shown to be necessary for 
mRNA export activity in combination with the viral pUL69 protein, which further 
contributes to efficient viral replication [60]. For HCMV a direct binding of pUL69 
to UAP56 or URH49 was observed. PUL69 is required for efficient export of 
Introduction 
 
 
 
16 
 
unspliced HCMV mRNA into the cytoplasm [59, 61]. A similar mechanism could 
also be possible for IAV. Until now only a small effect on viral replication could be 
shown for UAP56 and the mechanism for this remains poorly understood. For 
recent studies only human IAV strains where used and in addition nothing is 
known about the role of URH49 in IAV replication. 
 
Myxovirus resistance proteins (Mx) 
 
The interferon (IFN) type I system plays a pivotal role in the first line of defense 
against viral infections. Interferon synthesis and secretion is rapidly induced in 
infected cells due to the activities of virus sensors such as the toll like receptors 3 
or 7 or DEAD-box helicases RIG-I and MDA5 [27, 28]. These proteins recognize 
and bind virus-derived single stranded or double stranded RNA and induce a 
signalling cascade resulting in the activation of IFN type I genes [62]. IFN is 
secreted and binds to its cognate receptor predominantly in a paracrine fashion 
on neighboring cells, thereby inducing the synthesis of approximately 300 IFN 
type I-induced proteins. The combined activities of these proteins result in the 
generation of a so called antiviral state restricting the replication of many viruses 
[63]. Myxovirus resistance proteins have been first described in 1962 by 
J. Lindenmann to confer resistance to IAV in mice [64]. Until today Mx-proteins 
have been described in a number of species but we will focus on the murine Mx1 
protein and the human MxA protein in this work. Mx-proteins are exclusively 
induced by IFN α/β and human MxA exerts a broad antiviral activity against 
orthomyxoviruses, paramyxoviruses, bunyaviruses, rhabdoviruses, togaviruses, 
and hepatitis B virus [65]. 
Mx-proteins belong to a functionally diverse family of large GTPases with 
significant homologies to mammalian dynamins and yeast VPS-1 (vacuole 
protein sorting) [65]. Human MxA is homologous to dynamin sharing an N-
terminal G-domain (GTP binding and hydrolysis), a less well-defined middle 
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domain and a GTPase effector domain at the C-terminus. In humans two distinct 
forms are encoded on chromosome 21 that are termed MxA and MxB, of which 
only MxA has been shown to have antiviral activity. It was shown that mice which 
constitutively express MxA can survive otherwise lethal infections with IAV even if 
they lack the interferon receptor (IFNAR-/-) and therefore are not able to mount 
an antiviral state, which indicates that MxA is a key component of the interferon 
system [66].  
 
Molecular properties of human MxA and mouse Mx1 
MxA is localized in the cytoplasm and shows a characteristic granular staining 
pattern. The observed granules most likely represent Mx assemblies, which are 
associated with the smooth endoplasmic reticulum (ER) [67, 68]. All Mx-proteins 
share the common G-domain and a GTPase effector domain, but differ in length 
and size. In contrast to human MxA, murine Mx1 is located in the nucleus and 
shows a stronger inhibition of IAV replication compared to MxA. Mx-proteins are 
organized in an N-terminal moiety that comprises the GTP-binding domain and a 
C-terminal moiety that serves as the antiviral effector domain (Figure 2). Mx-
proteins exhibit an intrinsic GTPase activity that is essential for their antiviral 
function, nevertheless the exact function of the GTPase activity remains unclear 
and has to be further elucidated [69]. 
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Figure 7: Schematic drawing of human MxA. The N-terminal GTP-binding domain is shown in 
orange, middle domain is divided into two domains termed 2 and 3 since the biological functions 
of this domain are poorly understood, 3 and 2 are also referred to as the CID (central interactive 
domain). The C-terminal GED-domain is shown in light brown; arrows indicate a possible function 
of the GED-domain. No direct interaction between MxA and any IAV protein could be shown, but 
a cellular linker protein could be the missing link for the antiviral mechanism of MxA. 
 
Recently the crystal structure of the stalk region of MxA has been solved. The 
crystal structure further supports previous findings about oligomerization and GTP 
hydrolysis to have functional implications not only for MxA but also to all members 
of the dynamin family [70]. The stalk of MxA was shown to form a four-helical 
bundle, resulting in a structure that is important for the highly oligomeric order of 
MxA. Several mutants that were not able to form the four-helical bundle were 
lacking antiviral activity against IAV, indicating an important function for the 
antiviral activity of MxA [70]. Though the G-domain and the GTPase effector 
domain are known to be important for the antiviral activity, the molecular 
mechanism how MxA or Mx1 inhibit the IAV replication is not known. For 
thogotoviruses, another member of the Orthomyxoviridae, an interaction with the 
nucleocapsid was shown that inhibits the nuclear import of the viral nucleocapsids 
[71]. The replication of La Crosse virus (LACV), a member of the Bunyaviridae, is 
also inhibited by MxA via a sequestration of the nucleocapsids protein into 
perinuclear complexes [71-74]. No such mechanism could be demonstrated for 
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IAV or any other virus inhibited by MxA. However, there is evidence at which step 
MxA or Mx1 could inhibit IAV replication. The nuclear localized murine Mx1 was 
shown to inhibit viral mRNA synthesis, in contrast the cytoplasmic human MxA 
only blocked the amplification of the viral genome without affecting primary 
transcription [75]. These two different targets might be a result of the different 
intracellular localization of both proteins, since MxA was not shown to be present 
in the nucleus of infected cells. Interestingly, an MxA variant with the NLS of the 
simian virus 40 (SV-40) large T-antigen attached to its N-terminus, was shown to 
have a nuclear localization and inhibit IAV replication at the level of primary 
transcription, showing the importance of the cellular localization in terms of the 
antiviral activity [76]. Since no direct interaction between MxA and any IAV protein 
was detected, it might be an indirect interaction via a mediating cellular protein 
that is important for the antiviral effect. For MxA very few interactions with cellular 
proteins are known. MxA was shown to interact with actin and is believed to have 
a membrane binding activity [77]. For Mx1 a small number of interactions with the 
SUMO-1 protein modification system has been described, but so far none of this 
interactions proofed to be important for antiviral activity [77, 78].  
  
Introduction 
 
 
 
20 
 
Aims 
 
No direct interaction with any IAV protein was shown for MxA so far, which makes 
it possible for a cellular protein to mediate between MxA and components of the 
virus. In 2001 the cellular helicase UAP56 was shown to interact with the 
nucleoprotein of IAV and the interaction was verified in 2007 [58, 79]. UAP56 is a 
cellular RNA helicase involved in mRNA export and spliceosome assembly [51, 
80, 81]. Recently a close paralogue of UAP56 termed URH49 has been described 
having 90% identity on the amino acid level [48]. We addressed the question 
whether both RNA helicases interact with IAV NPs and play a role in IAV 
replication. Additionally we analyzed whether UAP56 and/or URH49 were able to 
bind MxA and/or Mx1 in different binding assays, making this a possible 
conjunction between the IAV NP or vRNP and MxA/Mx1. The goal of this study 
was to further elucidate the molecular mechanism of the interferon-induced 
human MxA and how it confers resistance to IAV and to show an involvement of 
cellular factors in the antiviral activity of MxA. 
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Abstract 
 
The cellular DEAD box RNA helicase UAP56 plays a pivotal role for efficient 
transcription/replication of influenza A virus. UAP56 is recruited by the 
nucleoprotein (NP) of influenza A viruses and recent data revealed that the RNA 
helicase is required for the nuclear export of a subset of spliced and unspliced 
viral mRNAs. The fact that influenza viruses do not produce detectable amounts 
of dsRNA intermediates during transcription/replication suggests the involvement 
of cellular RNA helicases. Hence, we examined whether the RNA unwinding 
activity of UAP56 or its paralogue URH49 plays a role in preventing the 
accumulation of dsRNA during infection. First, our data showed that not only 
UAP56 but also its paralogue URH49 can interact with NP of avian and human 
influenza A viruses. SiRNA-mediated depletion of either RNA helicase efficiently 
reduced transport of M1 RNA as well as NP mRNAs into the cytoplasm. 
Moreover, we found that virus infection of UAP56-depleted cells lead to a rapid 
accumulation of dsRNA in the perinuclear region. In parallel, we observed a 
robust virus-mediated activation of dsRNA-dependent protein kinase R (PKR) 
indicating that the cellular RNA helicase UAP56 may be recruited by the 
influenza virus to prevent dsRNA formation. Accumulation of dsRNA was blocked 
when actinomycin D or cycloheximide was used to inhibit viral 
transcription/replication or translation, respectively. In summary, we could 
demonstrate that UAP56 is utilized by influenza A viruses to prevent the 
formation of dsRNA and hence the activation of the innate immune response. 
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Introduction 
 
Influenza A viruses cause a highly contagious respiratory disease in humans and 
have been responsible for periodic wide-spread epidemics, or pandemics that 
have caused high mortality rates (22). The most devastating pandemic occurred 
in 1918, resulting in 20 to 50 million deaths worldwide. Influenza viruses are 
enveloped and their genome consists of eight negative stranded RNA segments 
coding for at least 10 proteins. While the majority of their viral mRNAs are 
intronless (mRNAs of segments 1 to 6), segments 7 (M) and 8 (NS) generate 
spliced as well as unspliced mRNAs (16). The viral genome is transcribed and 
replicated within the host cell nucleus by the virus encoded RNA-dependent RNA 
polymerase complex consisting of the three subunits PB1 (protein basic 1), PB2 
and PA (protein acidic). Synthesis of viral mRNA involves a “cap snatching” 
mechanism, whereby the cap structures of cellular precursor mRNA is cleaved 12 
to 15 nucleotides downstream of the cap by the endonuclease activity of PA (6). 
The capped oligonucleotides serve as primers for the initiation of the viral mRNA 
synthesis. Replication of the viral genomic RNA involves synthesis of a positive 
stranded complementary intermediate (cRNA) of the genomic RNA. Since the 
genome of influenza viruses does not encode for a helicase, which is required for 
the unwinding of dsRNA replicative intermediates, it has been suggested that the 
influenza virus polymerase complex may recruit cellular RNA helicases. In 
support of this, Momose and colleagues demonstrated that the nucleoprotein 
(NP) of influenza A virus binds to the DEAD box helicase UAP56 and that 
interaction between UAP56 leads to increased vRNA synthesis in vitro (21).  
UAP56 plays a pivotal role in spliceosome assembly as well as export of spliced 
and unspliced mRNA from the nucleus into the cytoplasm. UAP56 was first 
identified as an essential splicing factor that is required for pre-spliceosome and 
mature spliceosome assembly (9, 33, 34). Hereby, UAP56 as part of the 
transcription-export complex (TREX) recruits the Aly/REF nuclear export adaptor 
protein to the exon-junction complex (EJC) bound to pre-mRNAs and delivers it to 
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the export receptor NXF1 (4, 31). Further, UAP56 appears to be involved in 
proper translocation of mRNAs in the cytoplasm (20). URH49/DDX39 is a 
paralogue of UAP56 exhibiting 90% amino acid identity. URH49 appears to have 
a very similar function to UAP56 in nuclear RNA export (15, 27). Like UAP56, 
URH49 is able to interact with the nuclear export adaptor protein Aly and can 
partially complement the function of Sub2p the yeast homologue of UAP56 (27). 
Both URH49 and UAP56 can be detected in all mammalian cells and tissues but 
exhibit different expression profiles. While URH49 expression is clearly increased 
in proliferating cells, UAP56 levels remain constant (27). Concomitant 
downregulation with URH49 and UAP56 specific siRNAs leads to retention of 
poly(A)+ RNA in the nucleus and to cell death within 72 hours (15). So far there is 
no data available that would link URH49 to spliceosome assembly or cytoplasmic 
targeting of mRNPs. Growing evidence suggests that influenza viruses exploit the 
primary cellular mRNA nuclear export pathway for directing their mRNAs to the 
cytoplasm (2, 28, 38). Subsets of spliced and unspliced influenza virus mRNAs 
are exported into the cytoplasm in an UAP56/NFX1-dependent fashion. Read and 
colleagues recently showed that UAP56 is involved in the nuclear export of M1, 
M2 and NS1 mRNA, while the export of other viral mRNAs such as those 
encoding NS2, NP and HA appear to be independent from UAP56 (28). Hence, 
UAP56 participates in the nuclear export of spliced as well as unspliced viral 
mRNAs. In contrast the nuclear export of vRNPs is mediated by the CRM-1 
pathway independent of UAP56 (8).  
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In this study, we first sought to determine whether UAP56 and URH49 play a role 
in replication/transcription of influenza virus RNA. We observed that both URH49 
and UAP56 interact with NP protein from both avian and human influenza virus 
strains. Using siRNAs specific for either URH49 or UAP56 we found that 
downregulation of UAP56 or URH49 reduced accumulation of NP mRNAs in the 
cytoplasm. Most interestingly, we found that virus infection of cells with 
downregulated UAP56 leads to the rapid accumulation of dsRNA in the 
perinuclear region. In parallel, we observed a robust virus-dependent activation 
of dsRNA-dependent protein kinase R (PKR) in these cells, indicating that the 
function of the cellular RNA helicase UAP56 may be redirected by the influenza 
virus to evade the antiviral function of the interferon type I system. 
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Material and methods 
 
Cells and viruses: A549 and HEK 293T (ATCC) cells were cultured in DMEM 
(Gibco) supplemented with 10% FCS, 1% Pen/Strep (Gibco) and 1% Glutamax 
(Gibco). The human influenza strain A/PR8/34/(H1N1) (PR8), the avian strain 
A/FPV/Bratislawa/79/(H7N7), and the vesicular stomatitis virus Indiana (VSV) 
were previously described (26). Infections were carried out in DMEM 2% FCS, 
1% Pen/Strep and 1% Glutamax for FPV and VSV. For PR8 DMEM with 0.2% 
BSA (Roth), 1% Pen/Strep and 1% Glutamax and 0.5µg/ml trypsin was used. 
Cells were washed once with infectious medium afterwards infections were done 
for 30 minutes at room temperature, virus was aspirated and the cells were 
incubated in infectious media for the indicated amounts of time. Viral titers were 
determined by TCID50 with supernatants from infected cells. Madine darby canine 
kidney cells (MDCK) were used for virus titrations. Titrations were performed as 
previously described (26). Statistical significance was determined using the 
paired t test. 
Transfections and siRNA knockdowns: 293T cells were transfected at 80% 
confluency with jetPEI transfection reagent (Polyplus transfection) according to 
the manual. Validated stealth siRNAs were purchased from Invitrogen, medium 
GC control siRNA (Invitrogen, 12935-300), validated pooled siRNAs were used 
against URH49 (DDX39HSS141113, DDX39HSS141114, DDX39HSS141115, 
NM_005804.2) and UAP56 (BAT1HSS111847, BAT1HSS111848, BAT1HSS111
849, NM_004640.5). SiRNA transfections were done using HiPerFect (Qiagen) 
as described in the manufacturers manual. Transfections were performed in 
suspension using 6x104 cells per 24-well and 30nM siRNA. Knockdowns were 
confirmed via western blot analysis and qPCR. 
Western blot and co-immunoprecipitation assays: 293T cells were grown in 
10cm cell culture dishes (TPP) and transfected at 80% confluency with the 
indicated amounts of plasmid. 48 hours after transfection cells were lysed in 
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500µl lysis buffer (0.5 % Triton X-100, 20mM TRIS pH 7.5, 100mM NaCL, 50mM 
β-glycerolphosphate, 50mM sodiumfluoride, 1mM sodiumorthovanadate and a 
protease inhibitor cocktail (Roche). Coimmunoprecipitations were perfomed with 
1µg mouse anti-FLAG antibodies (SIGMA) for 4 hours at 4°C. 
Immunoprecipitations were done at room temperature for 1h using 50 µl protein-
G beads (Dynalbeads, Invitrogen). Samples were washed three times with lysis 
buffer and beads were taken up in 40µl SDS-Laemmli buffer and heated for 5 
minutes at 95°C. Samples were loaded on 10% SDS-gels followed by 
immunoblot analysis with different antibodies. Anti-FLAG antibody (1:3000, 
SIGMA) against mouse and rabbit, anti-URH49 (1:750, Acris), anti-UAP56 
(serum from mice immunized with a peptide of human UAP56), anti-NP mouse 
monoclonal HB65 (1:3) and polyclonal serum against FLUAV (1:1500), anti-Actin 
(1:2000, SCBT). Anti PKR and Phospho PKR (1:2000, Abcam), anti-FLUAV M1 
HB64 (1:3) was from ATCC. Primary antibodies were incubated overnight at 4°C 
and incubated the next day for 1 hour with anti-HRP-conjugated secondary 
antibodies from GE-Healthcare (1:10000). Membranes were analyzed on a Fuji 
imager using the Multi Gauge 3.0 software.  
Indirect immunofluorescence analysis: A549 cells were transfected with 
siRNA as indicated and grown on chamber slides for 72 hours. Cells were 
infected with MOI 5 of FPV or PR8 and fixed at the indicated time post infection 
with 4% paraformaldehyde and permeabilized with 0.5% Triton X-100 in PBS. 
Cells were washed twice with PBS and blocked for 30 minutes with 1% BSA. 
Primary and secondary antibodies were diluted in 1% BSA and incubated for 1 
hour at room temperature in the dark. Cells were washed three times after each 
step. Anti-dsRNA J2 antibody (1:4000, engscicons, Hungary), rabbit anti-FLUAV 
serum (1:300) were used as primary antibodies. As secondary antibodies, Alexa 
488 anti-rabbit and Alexa 594 anti-mouse (1:1000, Invitrogen) were used. 
Cycloheximide (75µg/ml) and actinomycin D (0.5µg/ml) were diluted from 
10mg/ml stocks in normal DMEM medium and incubated with the cells from 
1 hour before infection until fixation of the cells. Slides were mounted in 
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Fluoromount mounting medium containing DAPI (Southern biotech). Samples 
were analyzed with a Leica TCS SP5 microscope using the LAF software. 
Expression constructs and protein purification: URH49 and UAP56 were 
cloned into pGEX-3x (GE Healthcare) with an N-terminal GST fusion tag 
(URH49for: GATAAGAATTCCGCAGAACAGGATGTGGAAAACGATC (EcoRI), 
rev: CTAATGAATTCAATTTACCGGCTCTGCTCGATGTATGTG (EcoRI), UAP56
 for: 5‟ CTTATACCCGGGGCAGAGAACGATGTGGACAATG-3‟ (SmaI), UAP56-
rev: 5‟-CAATAATCCCGGGATAAACTACCGTGTCTGTTCAATGTA-3‟ (SmaI). 
Proteins were expressed in E.coli BL21 with 0.1mM IPTG for 4h at 32°C. 
Bacteria were harvested and lysed with six cycles of sonication for 30 seconds in 
tris lysis buffer (50mM Tris-HCl pH 8.0, 500mM NaCl, 0.1 % NP-40, 5mM MgCl2, 
10mM 2-mercaptoethanol, 10 % glycerol, protease inhibitor cocktail (Roche)). 
Lysates were cleared at 12‟000 g for 20 minutes and applied to a glutathione 
sepharose column (GE Healthcare Glutathione sepharose High Performance). 
Bound proteins were washed with tris wash buffer (50mM Tris-HCl pH 8.0, 
100mM KCl, 0.1 % NP-40, 5mM MgCl2, 10mM 2-mercaptoethanol, 10 % 
Glycerol), eluted with tris elution buffer (20mM Tris-HCl pH 8.0, 100mM KCl, 0.1 
% NP-40, 5mM MgCl2, 5mM 2-mercaptoethanol, 10mM reduced glutathione, 
20% glycerol) and dialysed against elution buffer without GSH. PR8-NP and 
FPV-NP were cloned into pQE-32 vectors (Invitrogen) containing an N-terminal 
6x HIS tag, using the following primers: 
PR8-NP-for: GATTATCCCGGGGCGTCTCAAGGCACCAAACGATC (SmaI), 
PR8-NP-rev: CATTAGGTCGACTTATCGTATTCCTCTGCATTGTC (SalI), 
FPV-NP-for: CATTACCCGGGGCGTCTCAAGGCACCAAACGATCTTATG (SmaI),
FPV-NP-rev: CGTAATCCCGGGGATTAATTAATTGTCATACTCCTCTGCATTGT
CTC (SmaI). Proteins were expressed in E.coli M15 pRep4 with 1.5mM IPTG 
overnight at 22°C. Bacteria were harvested and sonicated six times for 30 
seconds in tris lysis buffer containing 50mM imidazole. Lysates were cleared at 
12‟000 g for 20 minutes, applied to Ni-NTA columns (QIAGEN) , washed with tris 
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wash buffer containing 50mM imidazole), eluted with elution buffer (as described 
above but GSH replaced with 250mM imidazole) and dialysed against elution 
buffer without imidazole. 
 
ALPHA screen: The ALPHA screen assay (Perkin Elmer) was performed in a 
384-well OptiPlate with 25µl reaction volume. The recombinant proteins were 
incubated for 2 hours at room temperature at a final concentration of 30nM each 
protein in APLHA screen buffer (PBS pH 7.2, 0.1% BSA), together with 
AlphaLISA anti-GST acceptor beads and ALPHA screen Ni-chelate donor beads 
at a concentration of 20µg/ml. Interactions were analyzed in a Perkin Elmer 
Envision device. 
 
Real time PCR: pCMV-UAP56 was a gift from C. Basler and P. Palese (New 
York), UAP56 was cloned into pcDNA3.1 (Invitrogen) with primers containing an 
N-terminal FLAG tag: 
(For: CGAATTGGATCCGCCACCATGGACTACAAAGACGATGACGATAAA 
GCAGAGAACGATGTGGAC 
Rev: GGATGACTCGAGGGGCGAGTCTTCTACCGTGTCTGTTCAATGTAGGAG
G). FLAG-URH49 was a gift from P. Lischka (Erlangen, Germany). 
Nucleoproteins of PR8 and FPV were cloned into pcDNA3.1. RNA was isolated 
as previously described (25). Reverse transcription was performed using 
Superscript III (Invitrogen) according to the manufacturer`s protocol using either 
an oligo dT primer or a sequence specific primer (18S rRNA) and 1µg RNA. 
qPCR was carried out  using Eva-Green ready to use qPCR mix (Biotium) and 
specific primers for FPV-M1, FPV-M2, FPV-NP, FPV-NS1, FPV-HA and 
18S rRNA on an Applied Biosystems 7300 qPCR cycler (40x cycles 10 sec 95°C, 
20 sec 55 °C, 27 sec 72°C). For the 18s rRNA control reverse transcription was 
performed with a 18S rRNA specific primer. Sequence detection software 1.4 
was used to analyze the data. M1 for: GACCAATCCTGTCACCTC; M1 rev: 
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GATCCCCGTTCCCATTAAGGG; M2 for: GAGGTCGAAACGCCTAT; M2 rev: C
TCCAAGCTCTATGCTGACAAA; NP for TGTGCAACATCCTCAAAGGAAA; NP 
rev: GAGCCACTGATCCCCTCAGA¸ NS1 for: CATGCTCATGCCCAAACAGA; 
NS1 rev: TCCTCGGTGAAAGCCCTTAG; HA for: GCAGGTTGATGCCAATTGC; 
HA rev: TTCATCCCTGTTGCCAATAATAGA; 
18S rRNA for: CAAGACGGACCAGAGCGAAA; 18S rRNA rev: GGCGGGTCAT
GGGAATAAC. 
 
Northern blot: Northern blot analysis was performed as previously described 
(25). 10 µg of nuclear or cytoplasmic RNA were loaded per lane. After transfer of 
the separated RNAs onto nylon membranes the RNA was UV-crosslinked using 
a UV Stratalinker 1800 (Stratagene). Before hybridization the blots were stained 
with methylene blue in 0.3M sodium acetate pH 5.0 to visualize precursor rRNA 
28S and 18S RNA. Hybridization was carried out with DIG-labeled negative-
stranded RNA probes for NP and M using the Roche Northern Starter kit (Roche) 
according to the manufacturer‟s manuals. The RNA probes were in vitro 
transcribed from linearized plasmid templates containing the M and NP segment 
of FPV. The northern blots were analyzed on a Fuji imager. Bands representing 
M1 mRNA, NP mRNA or 18S rRNA were quantified using the Multi Gauge 3.0 
software. 
 
Results 
 
The overall goal of our study was to dissect the role of UAP56 in the course of 
the influenza A virus replication. Since all human cells express both UAP56 and 
its paralogue URH49, it was pivotal to monitor effects of both helicases on 
influenza A virus infection. First, we tested whether both URH49 and UAP56 
would interact with NP from human and/or avian influenza A virus strains. To this 
end, NP from the human influenza virus A/PR/8/34 (H1N1) or avian 
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A/FPV/Bratislawa/79/(H7N7) strain were coexpressed with FLAG-tagged human 
UAP56 or URH49 in human HEK 293T cells. UAP56 or URH49 were then 
immunoprecipitated and associated proteins analyzed by western blot. 
Interestingly, the NPs from both the human and avian influenza strains were 
capable of forming a complex with UAP56 as well as URH49 (Fig. 1A). The direct 
protein interaction between avian or human NP and URH49 as well as UAP56 
was confirmed in vitro using the ALPHA screen technique. The data show that in 
vitro URH49 and UAP56 interacted with similar affinity to NP derived from a 
human or an avian influenza A strain (Fig 1B). 
 
Influence of URH49 or UAP56 knockdown on viral titers 
We next tested whether the individual knockdown of URH49 or UAP56 would 
affect the efficiency of avian and human influenza A virus replication. For this 
purpose A549 cells were first transfected with pools of siRNAs specific for either 
URH49 or UAP56. Knockdown of the targeted proteins was verified by western 
blot analysis (Fig. 2A). Importantly, transfection of the siRNAs did not upregulate 
the expression of type I interferon (IFN)-inducible protein MxA (1, 36) 
demonstrating that  type I IFN was not induced by application of the siRNAs used 
in this study (Fig. 2A). Depletion of URH49 or UAP56 in A549 cells with specific 
siRNAs strongly affected the replication efficiency of both human and avian 
influenza A viruses (Fig. 2B to D). Knockdown of UAP56 or URH49 led to a 
reduction of avian A/FPV/Bratislawa/79(H7N7) titers by a factor of 200 and 5, 
respectively (Fig 2B). Similarly, we observed a significant (p<0.05) 5 and 50 fold 
titer reduction in UAP56- or URH49-depleted cells infected with a Zurich isolate 
of the pandemic H1N1 influenza virus (A/Zurich/8665/2009(H1N1)) (Fig 2D). 
Less pronounced but still significant reductions (p<0.05) of viral titers were 
observed with the laboratory strain A/PR/8/34(h1N1) were downregulation of 
UAP56 or URH49 led to a 20 and 5 fold decrease of viral titers (Fig. 2C). 
Surprisingly, infection with VSV also led to a significant (p<0.05) 5 and 9 fold titer 
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reduction at 12 hours post infection (p.i.) in UAP56 or URH49 knockdown cells, 
respectively (Fig 2E). To exclude the remote possibility that the observed 
reduction of influenza A virus titers in A549 cells depleted of URH49 or UAP56 
was simply due to induction of type I interferon by siRNA treatment, we repeated 
the experiment in transfected A549 cells stably expressing the V-protein of 
simian virus 5 (SV5) (Fig. S1). The-V protein is a potent inhibitor of the type I IFN 
mediated expression of type I IFN-induced effector proteins (7). As expected, 
A549 cells stably expressing the V protein were no longer capable of 
synthesizing MxA upon induction with saturating amounts of IFN-α2 (Fig. S1D). 
Nevertheless, in these cells titers of avian influenza A virus were reduced to the 
same extent as in A549 wild-type cells when either URH49 or UAP56 was 
depleted (Fig. S1A, B, C), indicating that the observed titer reduction were not 
simply the result of an interferon type I mediated antiviral response. 
 
Influence of URH49 or UAP56 knockdown on splicing and 
nuclear export of viral mRNAs 
To better define the step(s) of the influenza A replication cycle affected by 
depletion of URH49 or UAP56, we examined splicing and nuclear export of viral 
mRNAs of segment 7 (M-segment). Digard and colleagues have recently shown 
that UAP56 plays a role in the nuclear export of several human influenza A 
mRNAs namely M1, M2, NS1 and HA mRNA while the export of other viral 
mRNAs, in particular NP mRNA was largely independent of UAP56 (28). A549 
cells depleted of URH49 or UAP56 were infected with an MOI of 5 using avian 
influenza A virus for 4 hours. RNA isolated from the nuclear and cytoplasmic 
fraction was then analyzed either by northern blotting (Fig. 3A) using 
negative-stranded RNA probes specific for NP and M, or qPCR (Fig. 3B) using 
primers specific for M1,NP, HA and NS1 or primers specific for unspliced M1 
mRNA and spliced M2 mRNA (Fig. 3E). Northern blot analysis revealed that in 
cells transfected with control siRNA both the mRNAs coding for NP and M1 
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accumulated primarily in the cytoplasm (approximately 60%) (Fig. 3A, C and D). 
By contrast, depletion of UAP56 or URH49 reduced nuclear export of the NP and 
M1 RNA to the cytoplasm. Knockdown of URH49 limited accumulation of NP 
mRNA and M1 mRNA to 38% and 43%, respectively (Fig. 3A, C and D). 
Although depletion of UAP56 had a less pronounced effect on the nuclear export 
of NP and M1 mRNA the data clearly indicate that both helicases are involved in 
this process. When the RNA samples were analyzed by qPCR very similar 
results were obtained (Fig. 3B). Depletion of URH49 lead to a reduced export of 
M1 and NP RNA in into the cytoplasm (18% M1 RNA and 19% NP RNA in the 
cytoplasm) when compared to treatment with control siRNA (37% M1 and 28% 
NP RNA in the cytoplasm), while nuclear export of HA and NS1 RNA were only 
marginally affected.  Knockdown of UAP56 had a less pronounced effect on the 
nuclear export of M1 and NP (25% M1 RNA and 24% NP RNA in the cytoplasm) 
and again no effect on the export of HA or NS1 RNA. Furthermore, neither 
depletion of URH49 nor UAP56 had an influence on the ratio between the 
unspliced M1 and spliced M2 mRNA in the nuclear or cytoplasmic RNA fraction 
(Fig. 3E). The spliced M2 RNA accumulated to approximately 5% of the amount 
of M1 mRNA, suggesting that splicing of the M segment does not require the 
activity of URH49 or UAP56. However, we cannot exclude the possibility that 
UAP56 and URH49 have an overlapping function in assembly of the cellular 
splicing complex. Taken together, URH49 and to a certain extent UAP56 play a 
role in the nuclear export of viral mRNAs. However, the partial nuclear retention 
of M1 and NP in UAP56-depleted cells clearly does not explain the strong (200 
fold) reduction of FPV titer in these cells. 
 
Activation of dsRNA dependent protein kinase R (PKR) 
Both UAP56 and URH49 have been previously shown to exhibit RNA helicase 
(unwinding) activity (35, 37). It is therefore conceivable that URH49 and/or 
UAP56 play a role in preventing the generation of detectable dsRNA replicative 
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intermediates during influenza A replication/transcription. In contrast to 
positive-strand RNA viruses, negative-strand RNA viruses appear not to produce 
detectable amounts of viral dsRNA intermediates in infected cells (39). In order to 
address this question, we tested the accumulation of dsRNA by monitoring the 
phosphorylation of the dsRNA dependent protein kinase R (PKR). Binding of 
dsRNAs of more than 30 base pairs in length leads to activation of the latent PKR 
by dimerization and autophosphorylation (29). A549 cells depleted for URH49 or 
UAP56 were either mock infected or infected with human and avian influenza A 
virus for 4 hours. Protein extracts of these cells were analyzed by western blot 
using a phospho PKR-specific antibody (Fig. 4A). The data (Fig. 4B and C) 
revealed that depletion of URH49 or UAP56 resulted in a partial activation of 
PKR. Moreover, influenza A virus infection of cells treated with siRNA specific for 
URH49 or UAP56 strongly enhanced the activation of PKR. By contrast, no 
activation of PKR was evident in mock infected control siRNA treated cells and 
only a weak activation was observed upon infection (Fig 4C). In addition, 
immunostaining of M1 revealed a strong reduction of M1 protein expression in 
UAP56 or URH49-depleted cells that paralleled the observed reduction in virus 
yield (Fig 2B and C). Taken together, these observations indicate that URH49 
and UAP56 do indeed play a role in preventing the accumulation of dsRNA in 
virus infected cells. We also tested whether depletion of URH49 and UAP56 
would result in the synthesis of type I interferon. This was not the case, since we 
did not observe activation of the transcription factor IRF-3 or secretion of 
interferon-β by URH49 or UAP56-depleted cells, independent of whether they 
were infected or not (data not shown). 
 
Accumulation of dsRNA in UAP56-depleted cells 
The observed activation of PKR in URH49 or UAP56-depleted cells infected with 
influenza A virus could be the result of accumulation of dsRNA. To address this 
question we took advantage of a monoclonal antibody highly specific for dsRNA. 
Weber and colleagues have previously shown that infection with 
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positive-stranded but not negative-stranded RNA viruses, such as influenza, 
resulted in the accumulation of virus-specific dsRNA in host cells (39). We 
infected A549 cells following treatment with either control siRNA, siRNA specific 
for URH49 or UAP56 with avian (Fig. 5A) or human (Fig. 5B) influenza A virus for 
4 hours. As expected, in control siRNA-treated cells infection with influenza virus 
did not yield detectable levels of dsRNA (Fig 5A and B) In contrast, infection of 
UAP56-depleted cells led to a pronounced accumulation of dsRNA in the 
perinuclear region (Fig 5A and B). Notably, depletion of URH49 did not result in 
the accumulation of dsRNA in the infected cells despite the fact that we observed 
a considerable activiation of PKR in these cells (Fig. 4B). Mock infection of 
URH49-or UAP56-depleted cells yielded much lower levels of dsRNA suggesting 
that the observed dsRNA was predominantly of viral origin (Fig. 5C). The 
puzzling observation of perinuclear accumulation of dsRNA raised the possibility 
that the antibody detected incoming RNPs in a panhandle conformation (17) that 
may require unwinding before passage through the nuclear pore. To test this 
hypothesis, we treated the cells with actinomycin D before infection, thereby 
preventing de novo synthesis and nuclear export of viral RNAs (38). Evidently, 
inhibition of viral RNA synthesis strongly reduced the accumulation of dsRNA in 
UAP56-depleted cells. Nevertheless, small amounts of dsRNA located in the 
cytoplasm were detectable in UAP56-depleted and surprisingly, also in URH49-
depleted cells (Fig. 6A. The fact that dsRNA accumulated very early in the 
infection cycle, prompted us to test whether primary transcription by the virion-
associated polymerase complex (in the absence of synthesis of viral proteins) 
would provide sufficient amounts of viral RNA. This was clearly not the case, 
pretreatment of URH49- or UAP56-depleted cells with cycloheximide prevented 
the accumulation of dsRNA (Fig. 6B). Controls with mock infected cells only 
showed very low amounts of dsRNA in uninfected cells treated with UAP56 or 
URH49 (Figs. 5C, S2 panels A and B). 
In order to assess whether the observed activity of UAP56 or URH49 may also 
apply to other negative-strand viruses we infected URH49- or UAP56-depleted 
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A549 cells with VSV and looked for the accumulation of dsRNA using the 
dsRNA-specific antibody. Intriguingly, similar to influenza A virus infection, 
dsRNA accumulated to high levels in the perinuclear region of UAP56-depleted 
cells whereas dsRNA was not detectable in URH49 siRNA or control siRNA 
treated cells (Fig. 7). 
 
Discussion 
 
UAP56 has been shown to link mRNA transcription and splicing to nuclear export 
of cellular RNA. Although encoded by two distinct genes the RNA helicases 
UAP56 and URH49 show an identity of 90% at the amino acid level (27). There is 
mounting evidence that UAP56 is involved in nuclear export of influenza virus 
mRNAs (2, 28, 38). This raises the question of whether or not URH49 may also 
play a role in transcription/replication of influenza A viruses. Co-
immunoprecipitation and ALPHA screen assays have demonstrated that URH49 
is capable of binding NP from both avian and human influenza A viruses and 
does so with similar efficiency to UAP56 (Fig. 1). However, when we analyzed 
the function of URH49 and UAP56 in replication of avian and human influenza 
virus it became evident that only UAP56 was required for efficient replication of 
avian influenza (Fig. 2B), while both URH49 and UAP56 showed an intermediate 
effect for the human influenza A virus. A possible explanation for these 
observations is that for human influenza the two helicases exert a partially 
overlapping function. In this context, it is interesting to note that depletion of 
URH49 or UAP56 always resulted in increased expression of the paralogous 
helicase (Fig. 2A). Blasts of the chicken genome database for UAP56 and 
URH49 revealed the presence of only the gene homologue to UAP56. Hence, it 
is conceivable that human URH49 may only partially complement the activity of 
UAP56 in conjunction with the avian influenza A replication/transcription 
machinery. 
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Several previous studies have shown that export of  spliced as well as unspliced 
influenza mRNAs encoding late viral proteins are at least partially dependent on 
NFX1 and UAP56 (2, 13, 28, 38). By contrast, nuclear export of unspliced 
mRNAs encoding early gene products such as PB2 or NP appears to be largely 
independent of UAP56 viral mRNAs (28). However, in our experimental setting 
the export of the NP mRNA was clearly dependent on the presence of UAP56. 
The reason for this discrepancy between the two studies is not clear but may be 
explained by different cell lines and assays that were used. Further, our data 
demonstrate that URH49 is also involved in nuclear export of the viral NP and M1 
mRNA providing further support to the notion that URH49 exerts a similar 
function as UAP56 although forming distinct nuclear export complexes (41). 
The fact that during transcription/replication of negative-stranded RNA viruses, 
including influenza, dsRNA intermediates are not detectable (39) suggests the 
involvement of cellular RNA helicases. Hence, the association of UAP56 with 
vRNPs (19) may not only be crucial for nuclear export of viral mRNA but also for 
the prevention of formation of dsRNA replicative intermediates. The presence of 
dsRNA in infected cells plays a pivotal role in triggering the interferon type I 
response (12). This hypothesis prompted us to test whether depletion of UAP56 
or URH49 (i) result in accumulation of dsRNA and (ii) would lead to the activation 
of the dsRNA-dependent PKR. Since PKR is localized in the cytoplasm its 
pronounced activation in UAP56- or URH49-depleted cells pointed to the 
accumulation of dsRNA in the cytoplasm. Immunostaining of dsRNA using a 
specific antibody revealed that at least for UAP56 this was indeed the case (Fig 
5). Infection of UAP56-depleted cells with avian and human influenza A virus or 
VSV invariably led to the accumulation of dsRNA in the perinuclear region (Fig. 4 
and 6) thus providing an explanation for the activation of PKR. However, in the 
case of URH49 depletion, it is not clear why no dsRNA was detectable, despite 
the pronounced activation of PKR in these cells. A possible explanation for this 
finding may be that only small amounts of dsRNA were produced that were 
sufficient for the activation of PKR but not detectable by the anti-dsRNA antibody. 
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Alternatively, it is conceivable that UAP56 may be able to complement the 
unwinding activity of URH49 in the cytoplasm but not vice versa. So far a defined 
activity in the cytoplasm has only been demonstrated for UAP56 (20, 31).  
Recently, Burgui and colleages have shown that the influenza polymerase 
complex remains associated with the cap structure of the viral mRNA in the 
cytoplasm substituting for the function of the cellular factor eIF4E (3). Hence, it is 
tempting to speculate that UAP56 remains associated with the viral mRNA via 
the polymerase complex facilitating translation of the viral mRNA. Indeed, a 
function similar to the activity of eIF4A in protein translation has been recently 
shown for UAP56 in cardiomyocytes (30). 
Although, it is highly likely that the observed dsRNA is predominantly of viral 
origin we have no formal proof. Nevertheless, inhibition of the replication with 
actinomycin D or cycloheximide (allowing primary transcription) abrogated the 
formation of dsRNA. Recently, Dauber and colleagues have shown that in the 
absence of a functional NS1 protein cytoplasmic vRNPs are capable of inducing 
dsRNA-dependent PKR during the late phase of influenza B infection (5). 
Incidentally, B/NS1 has been reported to colocalize with several factors of the 
nuclear export machinery in nuclear speckles and to interact with UAP56 in vitro 
(32). However, inhibition of the CRM-1 mediated nuclear export of vRNPs by 
treatment with leptomycin had no effect on the accumulation of dsRNA (data not 
shown) strongly suggesting that the accumulating dsRNA in the perinuclear 
region does not consist of vRNPs (8). 
There is ample evidence that the NS1 protein of influenza viruses efficiently 
interfere with the activation of PKR (reviewed in (11, 40). Hence, the observed 
activation of PKR in influenza virus infected cells lacking either UAP56 or URH49 
could be due to low levels of NS1. Nuclear export of NS1 mRNA is reduced in 
cells depleted of UAP56 (28) or URH49 (data not shown). However, despite a 
pronounced activation of PKR, depletion of UAP56 or URH49 did not result in the 
synthesis of type I interferons in influenza virus infected cells. Neither did we 
observe activation of IRF3, nor were we able to detect even minute amounts of 
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interferon-β in culture supernatants (data not shown). It is conceivable that the 
observed inhibition of the interferon signalling cascade is due to the activity of low 
levels of NS1 interfering with activation of RIG-1 (10, 40) suggesting that the 
reduced amount of NS1 is still sufficient for interfering with the interferon type I 
response. In this context, it is interesting to note that Ostertag and colleagues 
reported that infection of host cells with a polR mutant of VSV (containing a 
single amino acid substitution in the N protein) resulted in the overproduction of 
viral dsRNA, and as a consequence, activation of PKR. Surprisingly however, the 
observed growth restriction of this mutant virus was independent of the interferon 
type I response (23, 24). Hence, it would be interesting to test whether the 
observed growth restriction phenotype of this VSV polR mutant could be linked to 
the activity of UAP56. 
It is intriguing that influenza-induced dsRNA was not observed in the nuclei of 
UAP56- nor URH49-depleted cells (Fig. 5). Since influenza viruses replicate in 
the host cell nucleus we would have expected accumulation of dsRNA primarily 
in the nucleus. One possible explanation is that URH49 and UAP56 may be able 
to complement their unwinding activity in the nucleus. Unfortunately, it is not 
possible to test this hypothesis since concomitant depletion of URH49 and 
UAP56 led to cell death within 72 hours of the start of siRNA treatment (data not 
shown) (see also (14, 15)).  
Taken together, we were able to show that the cellular RNA helicases UAP56 
and URH49 not only play a role in nuclear export of viral RNA but also prevent 
the formation of dsRNA and hence, the antiviral response of PKR in influenza 
virus and VSV-infected cells. Moreover, it will be interesting to elucidate whether 
the usurpation of activity of UAP56 may be a general viral strategy for evading 
the innate immune system. 
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Abstract 
 
Mx proteins are a family of large GTPases, which are exclusively induced by 
interferon- /  and have a broad antiviral activity against several viruses, 
including influenza A Virus (IAV), vesicular stomatitis (VSV) virus, thogotvirus 
(THOV) and La Crosse virus (LACV). Although the antiviral activity of human 
MxA has been studied extensively, only a very limited number of cellular factors 
have been described which directly interact with human MxA and the exact 
mechanism remains unclear and has to be further elucidated. We examined 
whether MxA directly interacts with two cellular helicases, UAP56 and URH49, 
which are involved in spliceosome assembly and nuclear mRNA export. UAP56 
and URH49 were recently shown to be important for IAV replication preventing 
the formation of dsRNA as well as leading to a nuclear accumulation of IAV 
segment specific mRNAs in knockdown cells for UAP56. Our data shows a direct 
interaction between MxA and UAP56 or URH49, which we could show 
endogenously as well as in vitro using ALPHA screen assays. Upon interaction 
we observed a translocation of UAP56 and URH49 into the cytoplasm of MxA 
expressing cells. Moreover, we established a split GFP system for MxA and 
UAP56 to confirm our interaction as well as the intracellular relocalization upon 
the interaction of MxA and the helicases. Taken together, we show a direct 
interaction for MxA and the two cellular helicases UAP56 and URH49, giving new 
insights into the molecular mechanism of human MxA. 
  
Manuscript 2 
 
 
 
58 
 
Introduction 
 
Mx proteins are a family of large GTPases, including dynamin, which can be 
found in most vertebrates. They play a pivotal role in the type I interferon 
mediated response against a broad range of viral infections [1]. Mx proteins 
share a high intrinsic GTPase activity and the ability to form large oligomeric 
structures [2-5].  The cytoplasmic human MxA has been described to inhibit 
several RNA and DNA viruses including influenza A virus (IAV), measles virus, 
vesicular stomatitis virus (VSV) or semliki forest virus [6-9].  Recently the crystal 
structure of the stalk region of MxA has been solved and in combination with 
similar structural data from dynamin a model for a four helical bundle formation of 
MxA was proposed [10]. MxA mutants lacking the ability to form oligomers were 
shown to have no antiviral activity against IAV [10]. Although the antiviral function 
of MxA has been studied extensively, little is known about the exact molecular 
mechanism of inhibition. MxA inhibits thogotovirus (THOV) infection via a 
physical interaction with the THOV nucleocapsid, blocking the nuclear import of 
THOV nucleocapsids [11]. For LACV an interaction between MxA and the LACV 
nucleoprotein was shown, which is sequestered by MxA into perinuclear regions 
[12]. MxA exhibits a typical granular staining pattern in the cytoplasm and 
associates partially with the smooth endoplasmic reticulum, suggesting a role in 
cellular trafficking [13]. However, for IAV no direct interaction of Mx-proteins with 
any viral protein could be shown, suggesting that cellular factors might be 
involved exerting a bridging function between MxA and IAV proteins. Momose 
and colleagues reported an interaction between the cellular DEAD box helicase 
UAP56 and IAV nucleoprotein (NP), which leads to an increased vRNA synthesis 
in vitro [14]. UAP56 plays an important role in the assembly of the spliceosome 
and in nuclear export of spliced and unspliced mRNA out of the nucleus. It has 
been first described as an essential splicing factor required for spliceosome 
assembly [15-17]. UAP56 is part of the transcription-export complex (TREX) and 
recruits the adaptor protein Aly/REF to the exon-junction complex (EJC) bound to 
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pre-mRNAs and subsequently guides the pre-mRNAs to the nuclear transcription 
factor (NFX1) resulting in nuclear export of the mRNAs [16, 19, 20]. Recently, a 
close paralogue of UAP56 termed UAP56-related helicase, 49kDa (URH49) has 
been identified that has 90% amino acid identity and exhibits similar cellular 
functions. Like UAP56, URH49 is able to bind Aly/REF and is able to complement 
the homologue Sub2p, in yeast [21]. Until now, no data is available for URH49 to 
be involved in spliceosome assembly, although it was shown for UAP56 and 
URH49 siRNA knockdowns to show a poly(A)+ RNA retention phenotype in the 
nucleus [22]. Knockdown of both helicases at the same time leads to cell death 
within 72 hours [22]. UAP56 and URH49 have been shown to be primarily 
located in the nucleus, accumulating in RNA-splicing speckled domains of the 
nucleus and nearby nuclear regions, although UAP56 was also reported to 
partially shuttle to the cytoplasm [20, 23, 24]. Furthermore, we recently 
demonstrated that UAP56 and URH49 are required for efficient IAV replication 
and prevention of dsRNA formation in cells infected with IAV (Wisskirchen et al). 
In this study, we addressed the question whether human MxA interacts with 
cellular factors, in particular with the cellular helicases UAP56 and URH49. We 
observed an interaction between human MxA or murine Mx1 and/or 
UAP56/URH49, using co-immunoprecipitations and ALPHA screen assays. In 
addition, we observed a change in the distribution pattern of UAP56 and URH49 
in cells expressing MxA, indicating a colocalization of the proteins under MxA 
expressing conditions, as well as showing a dominant-negative effect of UAP56 
or URH49 on an IAV mini-replicon system, which is comparable to the effect of 
MxA on IAV replication. Finally, we established a split GFP system to assess the 
direct interaction UAP56/URH49 and MxA using different constructs in living cells 
and trying to determine the exact subcellular localization of the interactions.  
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Materials and methods 
 
Cells and transfections: A549, 3T3 and HEK 293T (ATCC) cells were cultured 
in DMEM (Gibco) supplemented with 10% FCS, 1% Pen/Strep (Gibco) and 1% 
Glutamax (Gibco). Cells were transfected at 80% confluency with jetPEI 
transfection reagent (Polyplus) according to the manual and incubated for 24 
hours before being analyzed.  
 
Influenza A replicon system: The cDNAs of the viral polymerase subunits (PA, 
PB1 and PB2) and the viral nucleoprotein (NP) are derived from influenza 
A/Thailand/(KAN-1)/2004(H5N1) virus. 293T cells were seeded in 12-well plates 
and transfected with jetPEI (Polyplus). 10ng of plasmid were transfected for PB1, 
PB2 and PA and 100ng for NP together with 50ng of plasmid pPol-Luc-RT 
carrying the firefly luciferase reporter gene. For a transfection control 25ng of the 
Renilla luciferase-encoding plasmid pRL-SV40-Rluc (Promega) was 
cotransfected.  300ng of pcDNA3.1 MxA, UAP56 or URH49 were used. As a 
negative control, empty pcDNA3.1 vector was added in the same amount. Cells 
were lysed 24 hours after transfection and measured using a dual Luciferase 
assay (Promega). 
 
Western blot and co-immunoprecipitation assays: 293T cells were grown in 
10cm cell culture dishes (TPP) and transfected at 80% confluency with the 
indicated amounts of plasmid. 48 hours after transfection cells were lysed in 
500µl lysis buffer (0.5% Triton X-100, 20mM TRIS pH 7.5, 100mM NaCL, 50mM 
β-glycerolphosphate, 50mM sodiumfluoride, 1mM sodiumorthovanadate and a 
protease inhibitor cocktail (Roche). Co-immunoprecipitations were perfomed with 
1µg mouse anti-FLAG antibodys (SIGMA) for 4 hours at 4°C. 
Immunoprecipitations were done at room temperature for 1 hour using 50µl 
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protein-G beads (Dynalbeads, Invitrogen). Samples were washed three times 
with lysis buffer and beads were taken up in 40µl SDS-Laemmli buffer and 
heated for 5 minutes at 95°C. Samples were loaded on 10% SDS-gels followed 
by immunoblot analysis with different antibodies. Anti-FLAG antibody (1:3000, 
SIGMA) against mouse and rabbit, anti-URH49 (1:750, Acris), anti-UAP56 
(serum from a mouse immunized with a peptide of human UAP56), anti-NP 
mouse monoclonal HB65 (1:3). Primary antibodies were incubated overnight at 
4°C and incubated the next day for 1 hour with anti-HRP-conjugated secondary 
antibodies from GE-Healthcare (1:10000). Membranes were analyzed on a Fuji 
imager using the Multi Gauge 3.0 software.  
 
Expression constructs and protein purification: URH49 and UAP56 were 
cloned into pGEX-3x (GE Healthcare) with an N-terminal GST fusion tag 
(URH49-for: GATAAGAATTCCGCAGAACAGGATGTGGAAAACGATC (EcoRI), 
URH-49-rev:CTAATGAATTCAATTTACCGGCTCTGCTCGATGTATGTG (EcoRI), 
UAP56-for: CTTATACCCGGGGCAGAGAACGATGTGGACAATG (SmaI), 
UAP56-rev: CAATAATCCCGGGATAAACTACCGTGTCTGTTCAATGTA (SmaI). 
Proteins were expressed in E.coli BL21 with 0.1mM IPTG for 4 hours at 32°C. 
Bacteria were harvested, and lysed by six cycles of sonication for 30 seconds in 
tris lysis buffer (50mM Tris-HCl pH 8.0, 500mM NaCl, 0.1% NP-40, 5mM MgCl2, 
10mM 2-mercaptoethanol, 10% glycerol, protease inhibitor cocktail (Roche)). 
Lysates were cleared at 12‟000g for 20 minutes and applied to a glutathione 
sepharose column (GE Healthcare Glutathione sepharose High Performance). 
Bound proteins were washed with tris wash buffer (50mM Tris-HCl pH 8.0, 
100mM KCl, 0.1% NP-40, 5mM MgCl2, 10mM 2-mercaptoethanol, 10% glycerol), 
eluted with tris elution buffer (20mM Tris-HCl pH 8.0, 100mM KCl, 0.1% NP-40, 
5mM MgCl2, 5mM 2-mercaptoethanol, 10mM reduced glutathione, 20% glycerol) 
and dialysed against elution buffer without GSH. HIS-MxA and HIS-Mx1 have 
been previously described [5]. Proteins were expressed in E.coli M15 prep4 cells 
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with 10μM IPTG for 3 hours at 28°C. Bacteria were harvested, and lysed with two 
french press cycles in tris lysis buffer (50mM Tris-HCl pH 8.0, 500mM NaCl, 
0.1% NP-40, 5mM MgCl2, 10mM 2-mercaptoethanol, 30mM Imidazole, 10% 
glycerol, protease inhibitor cocktail (Roche)). Lysates were cleared at 20‟000g for 
20 minutes and applied to a glutathione sepharose column (GE Healthcare 
Glutathione sepharose High Performance). Bound proteins were washed with tris 
wash buffer (50mM Tris-HCl pH 8.0, 100mM KCl, 0.1% NP-40, 5mM MgCl2, 
10mM 2-mercaptoethanol, 30mM imidazole, 10% glycerol), eluted with tris elution 
buffer (20mM Tris-HCl pH 8.0, 100mM KCl, 0.1% NP-40, 5mM MgCl2, 5mM 2-
mercaptoethanol, 300mM imidazole, 20% glycerol) and dialysed against elution 
buffer without imidazole. 
 
ALPHA screen: The Alpha screen assays (Perkin Elmer) were performed in a 
384-well OptiPlate with 25µl reaction volume. The recombinant proteins were 
incubated for 2 hours at room temperature at a final concentration of 30nM in 
Alpha screen buffer (PBS pH 7.2, 0.1% BSA), together with AlphaLISA anti-GST 
acceptor beads and Alpha screen Ni-chelate donor beads at a concentration of 
20µg/ml. Interactions were analyzed using a Perkin Elmer Envision device. 
 
Split GFP system: First, the coding sequences of eGFP aa158-238 including the 
entire multiple cloning site (MCS) of pEGFP-C1 (Clontech) was amplified by PCR 
and ligated into the MCS of the pCDNA3.1 (-)neo vector (Invitrogen) yielding the 
vector pCDNA3.1-GFP158-238. To generate the vector pCDNA3.1 -GFP1-157 
the coding sequence of eGFP aa158-238 in the vector pCDNA3.1-GFP158-238 
was replaced by a PCR product encoding eGFP aa1-157. Subsequently the open 
reading frames of human MxA, MxB, UAP56 or URH49 were amplified and 
introduced in frame at the 3 „ end of the MCS of EGFP. Expression of the split 
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GFP fusion proteins was verified by western blot analysis using specific 
antibodies directed against GFP, Mx-protein or UAP56 and URH49. 
Indirect immunofluorescence analysis: A549 or 3T3 cells were grown on 
chamber slides for 24 hours before being transfected. Cells were fixed with 4% 
paraformaldehyde and mounted in DAPI containing mounting medium 
(Fluoromount, Southern biotech) when used with the split GFP system. 
Otherwise cells were permeabilized with 0.5% Triton X-100 in PBS for 10 
minutes. Cells were washed twice with PBS and primary and secondary 
antibodies were diluted in 1% BSA and incubated for 1 hour at room temperature. 
Cells were washed three times with PBS after each step. Anti-FLAG antibody 
(rabbit, 1:2000, Sigma), monoclonal mouse anti-MxA (1:20, Clone 143) were 
used as primary antibodies. As secondary antibodies, Alexa 488 anti-rabbit and 
Alexa 594 anti-mouse (1:1000, Invitrogen) were used. Samples were analyzed 
with a Leica TCS SP5 microscope using the LAF software. 
 
Results 
 
The goal of this study was to assess the interaction of human MxA with the 
cellular RNA helicases UAP56 and URH49 as well as to study the subcellular 
localization of MxA in vivo. We initially tested whether UAP56 and/or URH49 
directly interacted with MxA. For this purpose 293T cells were transfected with 
plasmids encoding FLAG-tagged UAP56 or URH49 in combination with plasmids 
encoding MxA. UAP56 and URH49 were immunoprecipitated with an anti-FLAG 
antibody and the lysates analyzed by western Blot (Fig. 1A). Both helicases, 
UAP56 as well as URH49, were shown to interact with MxA. To eliminate the 
possibility of a transfection artefact, we performed co-immunoprecipitations with 
endogenously expressed proteins and induced MxA expression by treatment with 
Interferon- . Human A549 cells were stimulated with Interferon-  overnight to 
induce MxA expression and immunoprecipitations were performed using a 
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monoclonal anti-MxA antibody. We analyzed the MxA-associated proteins with a 
polyclonal antibody detecting both UAP56 and URH49 (SantaCruz 
Biotechnology). As a control we performed an immunoprecipitaion using a 
monoclonal antibody against the IAV nucleoprotein (NP). Similar to co-
immunoprecipitations with ectopically expressed proteins we demonstrated an 
interaction between endogenously expressed MxA and UAP56/URH49 (Fig. 1B). 
To assess the binding affinity we tested the interaction of MxA and 
UAP56/URH49 in vitro using the ALPHA screen technology (Fig 2B). UAP56 and 
URH49 were expressed with an N-terminal GST-tag and MxA or Mx1 were 
expressed as HIS-tagged proteins in E.coli. The recombinant proteins were 
affinity purified and used in ALPHA screen assays to evaluate their relative 
binding strength (Fig. 2A). As a negative control GST only was incubated with 
MxA or Mx1. To evaluate whether the interaction with UAP56 and URH49 is a 
common feature of antivirally active Mx proteins we also tested murine Mx1. In 
contrast to MxA, Mx1 is located in the nucleus [25]. Analysis of the ALPHA 
screen results revealed a slightly stronger interaction for MxA and UAP56 when 
compared to the MxA and URH49 interaction. Surprisingly, the interaction of Mx1 
with UAP56/URH49 was 2-3 fold stronger as the interaction of MxA with the two 
helicases (Fig. 2A). Similar to MxA, the interaction between Mx1 and UAP56 
appeared to be slightly stronger than between Mx1 and URH49 (Fig. 2C) 
 
Intracellular localization of UAP56/URH49 and MxA 
We next wanted to address the question concerning the subcellular localization 
of the interaction between MxA and UAP56 or URH49. Since MxA is located in 
the cytoplasm and UAP56 and URH49 in the nucleus [22, 26]. We were 
interested to find out whether the localization of one of the proteins changed 
when both proteins were coexpressed [20, 27]. 3T3 cells were transfected with 
MxA and either FLAG-tagged URH49 or UAP56. As negative controls we 
expressed each of these proteins alone. Since 3T3 cells express no endogenous 
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Mx1, we could study the expression of the helicases in absence of endogenous 
Mx protein (Fig. 3). As expected, UAP56 and URH49 accumulated primarily in 
the nucleus forming nuclear speckles, as it has been previously described. MxA 
showed a clear cytoplasmic staining (Fig. 3). Interestingly upon coexpression of 
MxA with either UAP56 or URH49 we observed accumulation of UAP56 and 
URH49 in the cytoplasm of cells expressing MxA (Fig. 3) while MxA localization 
remained the same. UAP56 and URH49 were distributed throughout the whole 
cell. These results indicate that the described interaction (Fig. 1 and 2) takes 
place in the cytoplasm. 
 
Split GFP system to characterize the binding of MxA and 
UAP56/URH49 
To verify that the translocation of UAP56 and URH49 is the result of a direct 
interaction with MxA we constructed a split GFP system to further study the 
interaction between MxA and UAP56/URH49. For this purpose we adapted a 
system, which has been previously described [28, 29] fusing the amino acids 1-
157 or 158-238 of EGFP to the N-terminus of MxA, UAP56 and URH49, using a 
29 aa linker to allow an efficient refolding of the two GFP parts upon interaction of 
the fusion proteins. Since UAP56 and URH49 have been described to produce 
homodimers and heterodimers we used this technique to control our UAP56 and 
URH49 contructs [30] (Fig. 4). For MxA we used its ability to oligomerize as a 
positive control. We transfected MxA in combination with MxB as a negative 
control, since no interaction was described for these proteins. In addition, 
coexpression of the N- and C-terminal half of the GFP protein yielded no 
fluorescence signal [31]. We observed GFP signal when transfecting GFP1-157-
MxA and GFP158-238-MxA, although it was weaker than a full GFP fused to 
MxA (Fig. 4). As expected, we could see a dimerization of UAP56 or URH49. 
Upon cotranscfection of MxA and UAP56 or URH49 we observed GFP signal 
located in the cytoplasm, whereas the homodimers and heterodimer of UAP56 
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and/or URH49 were located in the nucleus (Fig. 4). These results support our 
data from the immunofluroescence assays, were similar patterns were observed, 
revealing a cytoplasmic localization for UAP56 or URH49 upon interaction with 
MxA. 
 
Dominant-negative effect of UAP56 or URH49 on IAV replication 
UAP56 and URH49 have been reported to have a dominant-negative effect on 
mRNA export if overexpressed [20]. In addition we could recently show that 
UAP56 is needed for efficient IAV replication as well as for prevention of dsRNA 
formation upon infection (Wisskirchen et al, submitted). To test whether 
overexpression of UAP56 or URH49 had an inhibitory effect on IAV replication 
we used a previously described IAV mini replicon system [32] and compared the 
results to the known inhibitory activity of MxA on IAV replication [10]. Indeed 
overexpression of UAP56 and URH49 led to a pronounced inhibition of IAV 
replication (Fig. 5), confirming our previous results, showing a stronger titer 
reduction for IAV in cells with a UAP56 knockdown compared to URH49 
knockdown cells (Wisskirchen et al, submitted). Surprisingly, the inhibition of 
replication was slightly stronger than for wildtype MxA, suggesting an effect for 
UAP56 and URH49 on IAV replication similar to the one described for MxA (Fig. 
5).  
 
Discussion 
 
The cellular RNA helicases UAP56 and URH49 play an important role in a variety 
of cellular processes. UAP56 is required for spliceosome assembly and export of 
spliced and unspliced mRNA out of the nucleus [16, 18, 20, 22]. Recently, 
UAP56 was also shown to be important for the nuclear export of certain IAV 
mRNAs [33]. In addition, UAP56 was shown to bind free viral NP and viral RNPs 
Manuscript 2 
 
 
 
67 
 
[14, 34]. We recently showed that UAP56 is also needed during IAV replication to 
prevent the accumulation of dsRNA in the cytoplasm of infected cells 
(Wisskirchen et al), submitted [2, 35]. For IAV and most other Mx-sensitive 
viruses no direct interaction between Mx-proteins and viral proteins was detected 
and the molecular mechanism of Mx-proteins against IAV remains elusive. 
UAP56 might be the missing link between Mx-proteins and IAV. In this study we, 
show that human MxA and murine Mx1 are indeed able to bind UAP56 and 
URH49 in vitro as well as in vivo (Fig. 1, 2). Intriguingly, we observed binding of 
MxA to UAP56 and URH49 in co-immunoprecipitation experiments despite the 
fact that MxA is located in the cytoplasm and UAP56/URH49 are predominantly 
located in the nucleus [20, 24, 27]. Our data clearly show that the interaction of 
MxA with UAP56/URH49 takes place in the cytoplasm (Fig. 3). Hence, supporting 
the hypothesis that UAP56 and URH49 are shuttling proteins, this is further 
supported by our recent observation (Wisskirchen et al, submitted) that 
knockdown of UAP56 leads to the accumulation of viral dsRNA in the cytoplasm. 
Previous studies revealed that MxA inhibits a step in IAV replication following 
primary transcription of mRNA, therefore retention of UAP56 or URH49 in the 
cytoplasm could be a possible working mechanism [36]. This would lead to an 
accumulation of UA56/URH49 in the cytoplasm and as a consequence less 
UAP56 would be available for spliceosome assembly and mRNA export. The 
primary target for MxA is most likely the mRNA export, since less spliceosome 
assembly would result in less primary transcription of viral mRNA, which was not 
shown for MxA. Mx1 exhibits a more efficient antiviral activity against IAV than 
MxA, which could have two possible explanations (Figure 1, 2) [5, 25, 37]. Either 
Mx1 binds to UAP56 and URH49 with higher strength than MxA, therefore less 
UAP56/URH49 would be available for spliceosome assembly and mRNA export, 
or the reason could be that Mx1 interferes with primary transcription, whereas 
MxA blocks a later step of IAV replication, most likely in the cytoplasm. Our 
recent findings about dsRNA accumulation in UAP56 knockdown cells infected 
with IAV (Wisskirchen et al, submitted) constitute additional evidence for a 
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cytoplasmic activity of UAP56. Hence, it is conceivable that MxA binds to UAP56 
and interfering with the RNA unwinding activity of UAP56, resulting in the 
observed accumulation of dsRNA. Alternatively, if UAP56 is required in the 
cytoplasm to redirect viral mRNAs to the ribosomes, this could also be inhibited 
via a direct binding of MxA and UAP56. To evaluate whether MxA binds directly 
to UAP56 or URH49 we established a split GFP system. Direct interaction of MxA 
with UAP56 or URH49 results in the correct association of the N- and C-terminal 
part of GFP (Fig 4.). Our data clearly show that MxA and UAP56 or URH49 
interact in the cytoplasm (Fig. 3, 4). A lot of research has been done using MxA 
mutants, which lack the ability to form oligomers or the GTPase ability, resulting 
in proteins, which have no antiviral activity [4, 10]. Using our system will allow us 
to further analyze if the binding of MxA to UAP56 or URH49 is affected in this 
mutants or if additional steps are involved in the mechanism of MxA. Since 
UAP56 is involved in mRNA export and splicing, it might also be interesting to 
take a closer look, whether MxA affects these cellular processes. Therefore the 
question rises whether UAP56 is primarily associated with viral RNA. There is 
growing evidence that the 5` end of viral RNAs exposed to the cytoplasm is 
associated with the polymerase complex of IAV in order to facilitate translation of 
viral mRNA [38]. Hence, UAP56 possibly remains associated with the viral 
polymerase-mRNA complex to facilitate translation via its unwinding activity 
thereby making it available for MxA. The interaction between IAV NP and URH49 
was also confirmed by our previous study, indicating a similar function for UAP56 
and URH49 in IAV replication, although UAP56 seems to be more important, 
since the titer reduction was higher in UAP56 than in URH49 knockdown cells 
(Wisskirchen et al, submitted). Taken together the interaction of MxA with UAP56 
and URH49 could represent a link between the antiviral activity of MxA against 
IAV, mediating between MxA and viral NP or RNPs.  
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Discussion 
 
The goal of this thesis was to address the question how the antiviral active 
proteins of the Mx-family affect the IAV replication and exert their antiviral 
potential. Despite numerous efforts by several research groups no evidence is 
known for a direct interaction of MxA with the viral NPs or RNPs leading us to 
hypothesize that Mx-proteins inhibit IAV replication via cellular factors. It was 
therefore conceivable to test cellular factors playing a role in IAV replication, 
which lead us to a detailed analysis of UAP56 and URH49 as possible 
candidates. 
 
Role of UAP56 and URH49 
UAP56 is a cellular mRNA helicase with several functions, including mRNA 
export and the involvement in multiple steps for spliceosome assembly and 
activity. UAP56 can recruit cellular factors including ALY/REF or CIP29 to the 
nascent mRNA and promotes nuclear export [50, 81, 82]. URH49 shares 90% 
identity at the amino acid level with UAP56 and was shown to have similar 
functions, though less is known about the exact role of URH49 [83]. UAP56 has 
been shown to stimulate IAV RNA synthesis in vitro, as well as to bind to IAV NP. 
UAP56 was also shown to be important for nuclear export of a set of IAV 
mRNAs, whereas not all viral mRNAs were dependent on UAP56, nothing is 
known for URH49 regarding IAV so far [36, 58, 79]. In this study we show that 
UAP56 and URH49 are important for IAV replication, since we observed a titer 
reduction in knockdown cells for UAP56 and URH49 (Manuscript 1, Figure 2). A 
set of different Influenza strains was used to infect knockdown cells and a 10-fold 
titer reduction was observed for UAP56 and a 5-fold reduction for URH49 using 
the human laboratory strain A/34/PR8/(H1N1) or a recent pandemic isolate 
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A/Zurich/8665/2009/(H1N1) (Manuscript 1, Figure 2 C, D). We showed that 
UAP56 appears to be much more important for the replication of avian IAV, 
resulting in a 200-fold titer reduction, whereas only a 5-fold reduction could be 
seen for URH49, suggesting that UAP56 plays an important role in avian IAV 
replication (Manuscript 1, Figure 2B). To test whether UAP56 and URH49 affect 
splicing or mRNA export of IAV we isolated cytoplasmic or nuclear RNA of 
infected cells and analyzed the splicing pattern of the M-segment as well as the 
export of NP, M1, HA and NS1 mRNAs via qPCR and or northern blot 
(Manuscript 1, Figure 3). Like previously published, UAP56 seems to affect the 
mRNA export of M1 mRNA, whereas a minor effect could be seen for HA and 
NS1 mRNA [36]. A similar effect was observed for URH49, but surprisingly the 
export of mRNAs was more strongly inhibited than in UAP56-knockdown cells 
(Manuscript 1, Figure 3), despite the fact that in URH49-knockdown cells viral 
titers were only slightly reduced. 
 
UAP56 prevents dsRNA accumulation 
Since the nuclear export phenotype did not appear to have a huge impact on viral 
titers, we next examined whether the unwinding activity of UAP56 and URH49 
play a role. IAV is lacking a virally encoded helicase and therefore, it may use a 
cellular RNA helicase for efficient replication. Because UAP56 and URH49 are 
both RNA helicases with a known dsRNA unwinding activity we wanted to 
address the question whether one or both helicases are involved in preventing 
the formation of dsRNA intermediates during IAV infection. IAV is known not to 
produce dsRNA intermediates, indicating an involvement of cellular RNA 
helicases [84]. To analyze whether dsRNA plays a role we first tested for a 
PKR-activation in UAP56- or URH49-siRNA knockdown cells. We observed a 
slight background of P-PKR in control siRNA cells infected with virus, but a 
stronger activation in knockdown cells infected with either FPV or PR8. Although 
we could also see P-PKR in mock infected UAP56 or URH49 knockdown cells 
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this is most likely because the helicases might be involved in the unwinding of 
cellular RNAs (Manuscript 1, Figure 4). Furthermore we tried to detect dsRNA 
using an immunofluroescence-based approach with an antibody specific for 
dsRNA. UAP56- or URH49-knockdown cells were infected with FPV or PR8 
virus. Infection with FPV and PR8 lead to an accumulation of dsRNA in UAP56 
knockdown cells whereas no dsRNA was observed in URH49 knockdown cells 
(Manuscript 1, Figure 5 A, B). A possible explanation might be that UAP56 is able 
to fully complement the function of URH49 but URH49 can complement UAP56 
only partially. To test whether the dsRNA was of viral origin we used actinomycin 
D to completely block IAV transcription or cycloheximide only allowing primary 
transcription but no amplification of viral RNA. Both inhibitors prevented the 
formation of dsRNA, indirectly ruling out that the observed dsRNA is of cellular 
mRNA origin, which should be still detectable otherwise (Manuscript 1, Figure 5 
A, B). In addition leptomycin B which is described to inhibit the CRM-1 dependent 
export of IAV RNPs [36, 38] had no effect on the dsRNA formation (data not 
shown), supporting our hypothesis of a viral mRNA versus vRNPs.  As an 
additional control we used VSV to exert a more general effect of UAP56 or 
URH49 on negative stranded RNA viruses. In UAP56 knockdown cells a 10-fold 
titer reduction was observed, whereas only a 4-fold reduction was observed for 
URH49 (Manuscript 1, Figure 2 E). Furthermore, we also detected dsRNA 
accumulation in VSV infected UAP56 knockdown cells, this was not the case for 
URH49, further supporting our observations for IAV. This makes UAP56 
potentially important for prevention of dsRNA formation during infection an 
additional virus, leading to an eventually more general mechanism (Manuscript 1, 
Figure 7). 
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MxA interacts with UAP56 and URH49 
Our initial findings, of both helicases interacting with human and avian IAV NPs 
(Manuscript 2, Figure 1 A, B) were made when we also tested whether the 
human MxA protein interacted with UAP56 or URH49. So far several groups 
have described the antiviral function of MxA, still leaving the mechanism unclear, 
since no direct interaction with any viral IAV protein was shown [65, 67, 75, 76, 
85]. We were able to show an interaction between exogenous as well as 
endogenous UAP56 or URH49 and human MxA (Manuscript 2, Figure 1 A, B). In 
addition, we performed in vitro ALPHA screen assays to analyze the binding of 
both helicases with MxA and Mx1 the murine member of the Mx-family. Mx1 
accumulates in the nucleus, in contrast to MxA. We observed a stronger relative 
binding of Mx1 to UAP56 or URH49 compared to MxA (Manuscript 2, Figure 2). 
We observed a similar correlation for the relative strength of the interaction 
comparing UAP56 and URH49, since the interaction with UAP56 and MxA or 
Mx1 was slightly stronger compared to URH49 and MxA or Mx1. Furthermore, 
we wanted to address the question in which cellular compartment the interaction 
between UAP56 and MxA takes place, since MxA is located in the cytoplasm and 
UAP56 and URH49 are both located in the nucleus forming characteristic nuclear 
speckles [65, 81]. Although MxA mutants with an NLS attached to their 
N-terminus are re-located to the nucleus have an even higher antiviral activity 
compared to wild type MxA. No shuttling of MxA has so been described so far or 
any interaction with nuclear proteins [76]. Cotransfection of MxA and UAP56 or 
URH49 in 3T3 cells lacking endogenous Mx1 resulted in a translocation of 
UAP56 and URH49 into the cytoplasm of the cells, whereas in control cells 
lacking MxA expression both UAP56 and URH49 remained confined to the 
nucleus. Although UAP56 has been previously hypothesized to play a role in 
mRNA translocation in the cytoplasm in redirecting mRNAs to the translation 
machinery, these findings give new insights into the role of both helicases 
(Manuscript 2, Figure 3) [86]. To verify a direct interaction between MxA and 
UAP56 or URH49 we established a split GFP system for MxA and the two 
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helicases. The GFP signal was complemented when a direct interaction of MxA 
with UAP56 or URH49 occurred. We used MxA and MxB as negative controls, as 
well as only the GFP parts, resulting in no signal. We observed a strong signal for 
the MxA/MxA interaction which is the result of the oligomerization of MxA, we 
also observed GFP signal for the homodimeric interactions of UAP56 and URH49 
as well as for the MxA-UAP56 and MxA-URH49 interaction, supporting our 
previous findings about this interaction (Manuscript 2, Figure 4). Although the 
homodimer of UAP56 and URH49 was present in the nucleus of the cell, the 
interaction of MxA-UAP56 and MxA-URH49 occurs in the cytoplasm of the cell, 
indicating that MxA is capable of retaining the two shuttling helicases in the 
cytoplasm. These results confirm our observations from the cotranscfection 
experiments. 
 
Dominate-negative effect of UAP56 or URH49 on IAV replication 
To demonstrate a link between IAV replication, UAP56/URH49 and the Mx-
proteins we then analyzed whether the described dominant-negative effect of 
UAP56 also plays a role in the context of an artificial mini replicon system of IAV. 
Cotransfection of the mini replicon system with MxA was used as a positive 
control. Surprisingly, we observed an even stronger reduction when UAP56 and 
URH49 were overexpressed (Manuscript 2, Figure 5). Taken together, we can 
demonstrate a pivotal role for UAP56 in IAV replication, as well as a direct 
interaction between MxA and UAP56 and URH49, giving us the opportunity to get 
more insights into the molecular mechanism of the function of MxA. So far, 
URH49 has been only described in mammals [48], whereas birds only express 
UAP56. This fact could be important, since we observed a 200-fold reduction of 
viral titer for avian IAV in UAP56 knockdown cells (Manuscript 1, Figure 2 B). We 
think this is due to a lack of compensation by URH49 since birds lack this gene. 
Therefore, the virus might not be able to utilize it as efficiently as human 
influenza viruses in case of a UAP56 knockdown. Since humans express UAP56 
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and URH49, the virus could adapt to the situation and use the available helicases 
for efficient replication. Nevertheless, UAP56 seems to play a more important 
role since it also prevents IAV from accumulating dsRNA in the cytoplasm of 
infected cells, whereas this was not the case in URH49 knockdown cells. We 
think that the prevention of dsRNA accumulation is one of the roles of UAP56, 
which his very plausible since IAV is believed to recruit cellular helicase and is 
known to be dependent on the cellular mRNA export machinery, thus making 
UAP56 an optimal candidate for this purpose. 
 
Working hypothesis for UAP56 and MxA 
In addition our data obtained with VSV revealed a more general role of UAP56 
for negative-stranded RNA virus replication, although there are major differences 
between VSV and IAV. Most importantly, VSV replicates in the cytoplasm of 
infected cells, whereas IAV replicates in the nucleus. Nevertheless, it would be 
interesting to test a VSV mutant that was described to have a single amino acid 
mutation in the N-protein resulting in production of large amounts of dsRNA, if 
this can be correlated with UAP56 or URH49 binding or utilization [87]. For VSV 
additional effects might be possible, since the virus is not as dependent on the 
cellular export machinery as IAV. Hence, it could have additional implications on 
cellular processes that are beneficial for an enhanced viral production, as long as 
they do not trigger any viral countermeasures, e.g. the type I interferon system. 
Since our initial focus was on MxA and a further elucidation of the molecular 
mechanism, the interactions of MxA and Mx1 with the two helicases could give 
us further insight into how this might work. Although UAP56 and URH49 are 
located in the nucleus of the cell, whereas MxA accumulates in the cytoplasm, 
we could show a retention of the two helicases into the cytoplasm by MxA. This 
strongly suggests that UAP56 and URH49 are shuttling proteins. To proof a more 
general involvement of UAP56 and URH49 we also tested Mx1 for an interaction 
with the two helicases, which was not surprisingly even higher than for MxA 
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(Manuscript 2). UAP56 and URH49 have been described to be important for the 
export of intronless mRNAs for human cytomegalovirus (HCMV), leading to 
replication deficient viruses when the viral pUL69 protein was mutated to be 
unable to bind UAP56 [60]. This data suggests a role for UAP56 and URH49 in 
different virus replication cycles and further underlines the importance of nuclear-
cytoplasmic shuttling of UAP56 and URH49 [61]. For UAP56 there is evidence 
that it might be important for redirecting mRNAs to their final destination in the 
cytoplasm, however this has so far only been shown in oocytes and not in human 
cells [86]. We could show that UAP56 and URH49 shuttle between nucleus and 
cytoplasm therefore making it very likely for them to have a function in the 
cytoplasm as well, which could be used either by the cellular mRNA export 
machinery, viruses or antiviral proteins. Since UAP56 is able to bind MxA and 
IAV NPs the results of our two studies can be combined to form a hypothesis 
how MxA interferes with IAV replication. Mx1 has been shown to inhibit primary 
transcription of IAV, still the exact mechanism remains unknown [75]. A possible 
explanation might be that Mx1 binds to UAP56 and or URH49 and therefore 
inhibits mature spliceosome assembly, which would result in an inhibition of viral 
and cellular transcription. This could further be supported by the model of 
Mx-protein oligomerization since data is available suggesting that the oligomeric 
form of Mx proteins is only a storage form, undergoing conformational changes to 
become antivirally active. Possibly MxA is antivirally active as a monomer but 
also becomes toxic for the cell itself [65, 88, 89]. Although this might be the fact 
for Mx1, we cannot assume this for MxA, since MxA  i) neither inhibits primary 
transcription of IAV but rather affects a later step in replication, ii) nor is there any 
evidence for nuclear-cytoplasmic shuttling of MxA. It is highly unlikely that MxA 
complexes passively diffuse through the nuclear pore complex since they are too 
large for this possibility, even if they would be actively imported the large size of 
the oligomers would prevent nuclear import. The interaction between NP and 
UAP56 can occur in the nucleus of the infected cell, whereas the interaction 
between UAP56 and MxA can only take place in the cytoplasm. It is therefore 
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possible that UAP56 is the common denominator between IAV NP and MxA, 
eventually allowing MxA to recruit UAP56 and/or URH49 for the antiviral activity, 
which would have several effects. MxA could make use of the nuclear-
cytoplasmic shuttling from UAP56 and URH49. A possible explanation is that 
MxA actively sequesters UAP56 and URH49 that shuttle out of the nucleus, 
leading to a decrease of the RNA helicases in the nucleus (Figure 8). Since it is 
known that UAP56 can stimulate viral RNA synthesis in vitro a lack of the 
helicase would result in less cRNA or vRNA, whereas fewer UAP56 available for 
mature spliceosome assembly would result in a lesser amount of viral mRNAs, in 
both cases this would lead to a less efficient viral replication [58]. 
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Figure 8: Working hypothesis of UAP56 and MxA 
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Taken together, we come up with two possibilities for the importance of the 
UAP56-MxA interaction to play a role in the mechanism of MxA. i) The interaction 
of MxA and UAP56 leads to a sequestration of the helicase therefore inhibiting an 
efficient viral mRNA export or maybe even the mRNA transport to the ribosomes. 
This is further supported by the findings of Read et al. and our own data 
(Manuscript 1), showing a nuclear retention of certain viral mRNA upon infection 
in UAP56 knockdown cells [36]. ii) The MxA-UAP56 interaction inhibits the 
helicase activity of UAP56, which could be further supported by our findings, that 
dsRNA accumulates in UAP56 knockdown cells infected with IAV (Manuscript 1, 
Figure 5). Both are possible scenarios and we will further investigate our 
hypotheses to gain further insights regarding a possible molecular mechanism of 
MxA. In summary, we could describe an interaction between MxA and the two 
cellular helicases UAP56 and URH49, which was also shown for the murine 
homologue Mx1. In addition, we showed that UAP56 plays a pivotal role in IAV 
replication, preventing the formation of dsRNA during infection. Thus, we could 
describe for the first time a direct interaction of MxA with two nuclear RNA 
helicases, as well as the involvement of two cellular helicases for IAV replication. 
UAP56 appears to be the cellular factor bridging an interaction between MxA and 
IAV NP and we will try to investigate this more in detail in the future. 
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